TW201811864A - Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device - Google Patents

Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device Download PDF

Info

Publication number
TW201811864A
TW201811864A TW105131504A TW105131504A TW201811864A TW 201811864 A TW201811864 A TW 201811864A TW 105131504 A TW105131504 A TW 105131504A TW 105131504 A TW105131504 A TW 105131504A TW 201811864 A TW201811864 A TW 201811864A
Authority
TW
Taiwan
Prior art keywords
formula
liquid crystal
crystal alignment
bis
compound
Prior art date
Application number
TW105131504A
Other languages
Chinese (zh)
Other versions
TWI659981B (en
Inventor
王建智
張維倫
Original Assignee
奇美實業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 奇美實業股份有限公司 filed Critical 奇美實業股份有限公司
Priority to TW105131504A priority Critical patent/TWI659981B/en
Priority to CN201710872247.6A priority patent/CN107880902B/en
Publication of TW201811864A publication Critical patent/TW201811864A/en
Application granted granted Critical
Publication of TWI659981B publication Critical patent/TWI659981B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1085Polyimides with diamino moieties or tetracarboxylic segments containing heterocyclic moieties
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Nonlinear Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Mathematical Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Optics & Photonics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

A liquid crystal alignment agent capable of forming a liquid crystal alignment film with excellent accumulated charge removability, the liquid crystal alignment film, and the liquid crystal display element with the said liquid crystal alignment film are provided. The liquid crystal alignment agent includes a polymer (A), and a solvent (B). Polymer (A) is obtained by reacting a mixture. The mixture includes a tetracarboxylic dianhydride component (a) and a diamine component (b). The tetracarboxylic dianhydride component (a) includes a compound (a1) represented by formula (a-1).

Description

液晶配向劑、液晶配向膜以及液晶顯示元件Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

本發明是有關於一種液晶配向劑、液晶配向膜以及液晶顯示元件,且特別是有關於一種可快速消除積蓄電荷的液晶配向劑、由上述液晶配向劑形成的液晶配向膜以及具有上述液晶配向膜的液晶顯示元件。The present invention relates to a liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display element, and more particularly to a liquid crystal alignment agent capable of quickly eliminating accumulated charge, a liquid crystal alignment film formed from the liquid crystal alignment agent, and the liquid crystal alignment film. Liquid crystal display element.

近年來,各界積極致力於開發新穎的液晶顯示元件。以橫向電場型的液晶顯示元件為例,橫向電場型(horizontal electric field type)的液晶顯示元件是將兩個電極在一對相對的基板的一側上,並且將該些電極以櫛齒狀(pectinate shape)的方式進行設置。該些電極可產生與基板平行的電場,進而控制液晶分子。上述元件通常被稱為共面切換(in-plane switching;IPS)型液晶顯示元件。In recent years, various circles have been actively committed to the development of novel liquid crystal display elements. Taking a horizontal electric field type liquid crystal display element as an example, a horizontal electric field type liquid crystal display element has two electrodes on one side of a pair of opposing substrates, and the electrodes are dentate ( pectinate shape). These electrodes can generate an electric field parallel to the substrate, thereby controlling the liquid crystal molecules. The above-mentioned element is generally called an in-plane switching (IPS) type liquid crystal display element.

日本專利特開2002-131751號公報揭示一種使用具有單苯環的二胺化合物的液晶配向劑,使用該液晶配向劑可得到預傾角低於2°的液晶配向膜,且應用該液晶配向膜可得到廣視角及高對比的IPS型液晶顯示元件。然而,該液晶配向劑卻有積蓄電荷消除緩慢,導致殘留電荷過高,進而生成殘影之問題。因此,如何提供一種可形成積蓄電荷消除性佳的液晶配向膜的液晶配向劑,使其所形成的液晶配向膜應用於液晶顯示元件時能有更良好的顯示品質,實為目前本領域技術人員亟欲解決的問題。Japanese Patent Laid-Open No. 2002-131751 discloses a liquid crystal alignment agent using a diamine compound having a single benzene ring. Using the liquid crystal alignment agent, a liquid crystal alignment film having a pretilt angle of less than 2 ° can be obtained. A wide viewing angle and high contrast IPS type liquid crystal display element is obtained. However, the liquid crystal alignment agent has a problem that the accumulated charges are slowly eliminated, resulting in excessive residual charges, and further generation of afterimages. Therefore, how to provide a liquid crystal alignment agent capable of forming a liquid crystal alignment film with excellent charge storage elimination property, so that the formed liquid crystal alignment film can have better display quality when applied to a liquid crystal display element is actually a person skilled in the art. Problems to be solved.

有鑑於此,本發明提供一種用於液晶顯示元件的液晶配向劑,使用該液晶配向劑所製得的液晶配向膜能夠改善積蓄電荷消除緩慢的問題。In view of this, the present invention provides a liquid crystal alignment agent for a liquid crystal display element. The liquid crystal alignment film prepared by using the liquid crystal alignment agent can improve the problem of slow accumulation of charge elimination.

本發明提供一種液晶配向劑,包括:聚合物(A)、以及溶劑(B)。其中,聚合物(A)是由混合物反應而獲得,混合物包括四羧酸二酐組份(a)及二胺組份(b)。四羧酸二酐組份(a)包括由式(a-1)表示的化合物(a1):式(a-1) 式(a-1)中,L1 各自獨立表示氫原子、碳數為1至10的烷基、碳數為1至10的烷氧基、氟原子、氯原子或溴原子;L2 各自獨立表示碳數為1至3的烷基。 a各自獨立表示0至3的整數;b表示0至4的整數。The invention provides a liquid crystal alignment agent, which includes a polymer (A) and a solvent (B). The polymer (A) is obtained by reacting a mixture, and the mixture includes a tetracarboxylic dianhydride component (a) and a diamine component (b). The tetracarboxylic dianhydride component (a) includes the compound (a1) represented by the formula (a-1): Formula (a-1) In formula (a-1), L 1 each independently represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, a fluorine atom, a chlorine atom, or bromine Atom; L 2 each independently represents an alkyl group having 1 to 3 carbon atoms. a each independently represents an integer from 0 to 3; b represents an integer from 0 to 4.

在本發明的一實施例中,上述的二胺組份(b)包括由式(b-1)表示的二胺化合物(b1):式(b-1) 式(b-1)中,R1 各自獨立表示氫原子、碳數為1至10的烷基、碳數為1至10的烷氧基、乙醯胺基、氟原子、氯原子或溴原子;R2 各自獨立表示碳數為1至3的烷基。 m各自獨立表示0至3的整數;n表示0至4的整數。In an embodiment of the present invention, the diamine component (b) includes a diamine compound (b1) represented by the formula (b-1): Formula (b-1) In formula (b-1), R 1 each independently represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, an acetamido group, or a fluorine atom. , A chlorine atom or a bromine atom; R 2 each independently represents an alkyl group having 1 to 3 carbon atoms. m each independently represents an integer from 0 to 3; n represents an integer from 0 to 4.

在本發明的一實施例中,上述的式(b-1)中,R1 各自獨立表示氫原子、碳數為1至10的烷基、碳數為1至10的烷氧基或乙醯胺基。In an embodiment of the present invention, in the formula (b-1), R 1 each independently represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, or acetamidine. Amine.

在本發明的一實施例中,上述的二胺組份(b)包括由式(b-2)表示的二胺化合物(b2):式(b-2) 式(b-2)中,h表示1至12的整數。In an embodiment of the present invention, the diamine component (b) includes a diamine compound (b2) represented by the formula (b-2): Formula (b-2) In Formula (b-2), h represents an integer of 1-12.

在本發明的一實施例中,基於四羧酸二酐組份(a)的總莫耳數為100莫耳,由式(a-1)表示的化合物(a1)的使用量為2至20莫耳。In an embodiment of the present invention, the total mole number based on the tetracarboxylic dianhydride component (a) is 100 moles, and the amount of the compound (a1) represented by the formula (a-1) is 2 to 20 Mor.

在本發明的一實施例中,基於二胺組份(b)的總莫耳數為100莫耳,由式(b-1)表示的二胺化合物(b1)的使用量為2至20莫耳。In one embodiment of the present invention, the total mole number of the diamine component (b) is 100 moles, and the amount of the diamine compound (b1) represented by the formula (b-1) is 2 to 20 moles. ear.

在本發明的一實施例中,基於二胺組份(b)的總莫耳數為100莫耳,由式(b-2)表示的二胺化合物(b2)的使用量為10至80莫耳。In one embodiment of the present invention, the total mole number based on the diamine component (b) is 100 moles, and the amount of the diamine compound (b2) represented by the formula (b-2) is 10 to 80 moles. ear.

在本發明的一實施例中,基於聚合物(A)的總使用量為100重量份,溶劑(B)的使用量為800至4000重量份。In one embodiment of the present invention, the total amount of the polymer (A) is 100 parts by weight, and the amount of the solvent (B) is 800 to 4000 parts by weight.

本發明也提供一種液晶配向膜,其是由如上述的液晶配向劑所形成。The present invention also provides a liquid crystal alignment film formed of the liquid crystal alignment agent as described above.

本發明更提供一種液晶顯示元件,包含如上述的液晶配向膜。The present invention further provides a liquid crystal display device including the liquid crystal alignment film as described above.

基於上述,本發明的液晶配向劑因含有特定的聚合物(A),因而能夠形成可快速消除積蓄電荷的液晶配向膜。Based on the above, since the liquid crystal alignment agent of the present invention contains the specific polymer (A), it is possible to form a liquid crystal alignment film that can quickly eliminate the accumulated charge.

為讓本發明的上述特徵和優點能更明顯易懂,下文特舉實施例,並配合所附圖式作詳細說明如下。In order to make the above features and advantages of the present invention more comprehensible, embodiments are hereinafter described in detail with reference to the accompanying drawings.

液晶配向劑 本發明提供一種液晶配向劑,包括:聚合物(A)以及溶劑(B)。此外,視需要,液晶配向劑可更包括添加劑(C)。 < Liquid crystal alignment agent > The present invention provides a liquid crystal alignment agent, which includes a polymer (A) and a solvent (B). In addition, if necessary, the liquid crystal alignment agent may further include an additive (C).

以下將詳細說明用於本發明的液晶配向劑的各個成分。聚合物( A Hereinafter, each component of the liquid crystal alignment agent used in the present invention will be described in detail. Polymer ( A )

聚合物(A)是選自聚醯胺酸聚合物、聚醯亞胺聚合物、聚醯亞胺系嵌段共聚合物或上述聚合物的任意組合。其中,聚醯亞胺系嵌段共聚合物是選自聚醯胺酸嵌段共聚合物、聚醯亞胺嵌段共聚合物、聚醯胺酸-聚醯亞胺嵌段共聚合物或上述聚合物的任意組合。The polymer (A) is selected from a polyamic acid polymer, a polyimide polymer, a polyimide-based block copolymer, or any combination thereof. The polyimide-based block copolymer is selected from the group consisting of a polyimide block copolymer, a polyimide block copolymer, a polyimide-polyimide block copolymer, or Any combination of the above polymers.

聚合物(A)中的聚醯胺酸聚合物、聚醯亞胺聚合物及聚醯亞胺系嵌段共聚合物均可由包括四羧酸二酐組份(a)及二胺組份(b)的混合物反應所製得,其中四羧酸二酐組份(a)、二胺組份(b)及製備聚合物(A)的方法如下所述。四羧酸二酐組份 a The polyfluorinated acid polymer, the polyfluorinated imine polymer, and the polyfluorinated block copolymer in the polymer (A) may each include a tetracarboxylic dianhydride component (a) and a diamine component ( b) The mixture is prepared by reacting the tetracarboxylic dianhydride component (a), the diamine component (b), and the method for preparing the polymer (A) as follows. Tetracarboxylic dianhydride component ( a )

四羧酸二酐組份(a)包括由式(a-1)表示的化合物(a1)、以及其他四羧酸二酐化合物(a2)。由式 (a-1) 表示的化合物( a1 The tetracarboxylic dianhydride component (a) includes the compound (a1) represented by the formula (a-1), and other tetracarboxylic dianhydride compounds (a2). Compound ( a1 ) represented by formula (a-1 )

由式(a-1)表示的化合物(a1)如下所示:式(a-1) 式(a-1)中,L1 各自獨立表示氫原子、碳數為1至10的烷基、碳數為1至10的烷氧基、氟原子、氯原子或溴原子;L2 各自獨立表示碳數為1至3的烷基。 a各自獨立表示0至3的整數;b表示0至4的整數。The compound (a1) represented by the formula (a-1) is shown below: Formula (a-1) In formula (a-1), L 1 each independently represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, a fluorine atom, a chlorine atom, or bromine Atom; L 2 each independently represents an alkyl group having 1 to 3 carbon atoms. a each independently represents an integer from 0 to 3; b represents an integer from 0 to 4.

由式(a-1)表示的化合物(a1)可以使用適當的有機化學的標準方法之組合進行合成。以下列舉具體例說明由式(a-1)表示的化合物(a1)的合成方式。The compound (a1) represented by the formula (a-1) can be synthesized using a combination of standard methods of appropriate organic chemistry. Specific examples will be described below to describe the synthesis method of the compound (a1) represented by the formula (a-1).

具體來說,由式(a-1)表示的化合物(a1)可經過下列兩個步驟的反應而獲得: 步驟(i):在鈀化合物、有機磷化合物以及鹼存在的情形下,使如下述式(a-1a)、式(a-1b)所示的化合物在溶劑中反應,以形成如下述式(a-1c)所示的化合物。此時,在溶劑中也可含有亞磺酸鹽。 步驟(ii):使如下述式(a-1c)所示的化合物中的羧酸基進行脫水環化反應,以生成由式(a-1)表示的四羧酸二酐化合物。式(a-1a)~式(a-1c)中,L1 、L2 、a、b的定義與式(a-1)相同。X表示鹵素原子、經取代或未經取代的烷基磺醯基氧基、或者經取代或未經取代的芳基磺醯基氧基。L3 各自獨立表示氫原子、或者碳數為1至10的烷基,上述的烷基為直鏈型或分支型。Specifically, the compound (a1) represented by the formula (a-1) can be obtained through the following two-step reaction: Step (i): In the presence of a palladium compound, an organophosphorus compound, and a base, make it as follows The compound represented by the formula (a-1a) or (a-1b) is reacted in a solvent to form a compound represented by the following formula (a-1c). In this case, the solvent may contain a sulfinate. Step (ii): The carboxylic acid group in the compound represented by the following formula (a-1c) is subjected to a dehydration cyclization reaction to generate a tetracarboxylic dianhydride compound represented by the formula (a-1). In the formulae (a-1a) to (a-1c), the definitions of L 1 , L 2 , a, and b are the same as those in the formula (a-1). X represents a halogen atom, a substituted or unsubstituted alkylsulfonyloxy group, or a substituted or unsubstituted arylsulfonyloxy group. L 3 each independently represents a hydrogen atom or an alkyl group having 1 to 10 carbon atoms, and the alkyl group is a linear or branched type.

L3 所定義的碳數為1至10的烷基,舉例而言可為甲基、乙基、丙基、異丙基、正丁基、異丁基、第二丁基、正戊基等基團。The alkyl group having a carbon number of 1 to 10 as defined by L 3 may be methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, second butyl, n-pentyl, etc. Group.

作為溶劑的具體例,可列舉下列具體例:二氯甲烷、氯仿、二噁烷、苯、甲苯、己烷、乙酸乙酯、四氫呋喃、乙腈、丙酮以及N,N-二甲基甲醯胺。溶劑可僅使用一種或同時混用多種,較佳為氯仿、甲苯或己烷等。Specific examples of the solvent include the following specific examples: methylene chloride, chloroform, dioxane, benzene, toluene, hexane, ethyl acetate, tetrahydrofuran, acetonitrile, acetone, and N, N-dimethylformamide. The solvent may be used singly or in combination of a plurality of solvents, and chloroform, toluene or hexane is preferred.

作為鈀化合物的具體例,可列舉下列具體例:醋酸鈀、氯化鈀、三(二亞苄基丙酮)二鈀、二(二亞苄基丙酮)鈀、四(三苯基膦)鈀、[1,1’-二(二苯基膦)二茂鐵]二氯鈀、二(三-鄰甲苯基膦)二氯化鈀、二(三苯基膦)二氯化鈀、乙醯丙酮鈀、鈀碳(Pd-C)、二氯二(乙腈)鈀、二(苯基氰)氯化鈀、(1,3-二異丙基咪唑-2-亞基)(3-氯吡啶基)二氯化鈀。鈀化合物較佳為乙酸鈀、氯化鈀或鈀碳(Pd-C)等。Specific examples of the palladium compound include the following specific examples: palladium acetate, palladium chloride, tris (dibenzylideneacetone) dipalladium, bis (dibenzylideneacetone) palladium, tetrakis (triphenylphosphine) palladium, [1,1'-bis (diphenylphosphine) ferrocene] dichloropalladium, bis (tri-o-tolylphosphine) palladium dichloride, bis (triphenylphosphine) palladium dichloride, acetamidine acetone Palladium, palladium carbon (Pd-C), dichlorobis (acetonitrile) palladium, di (phenylcyano) palladium chloride, (1,3-diisopropylimidazol-2-ylidene) (3-chloropyridyl) ) Palladium dichloride. The palladium compound is preferably palladium acetate, palladium chloride, or palladium carbon (Pd-C).

作為有機磷化合物的具體例,可列舉下列具體例:三苯基膦、三(鄰甲苯基)膦、9,9-二甲基-4,5-二(二苯基膦基)黃嘌呤、三(第三丁基)膦、二(第三丁基)甲基膦、二金剛烷基丁基膦、1,1’-二(二苯基膦基)二茂鐵、1,2-二(二苯基膦基)乙烷、1,3-二(二苯基膦基)丙烷、1,4-二(二苯基膦基)丁烷、2,2’-二(二苯基膦基)-1,1’-聯萘、三環己基膦、二苯基環己基膦、二環己基苯基膦、二苯基膦基二茂鐵、2-(二-第三丁基膦基)聯苯、三(第三丁基)鏻四苯基硼酸鹽、二(第三丁基)甲基鏻四苯基硼酸鹽。有機磷化合物較佳為二金剛烷基丁基膦、三(第三丁基)膦或三環己基膦等。Specific examples of the organic phosphorus compound include the following specific examples: triphenylphosphine, tri (o-tolyl) phosphine, 9,9-dimethyl-4,5-bis (diphenylphosphino) xanthine, Tris (third butyl) phosphine, bis (third butyl) methylphosphine, diadamantylbutylphosphine, 1,1'-bis (diphenylphosphino) ferrocene, 1,2-di (Diphenylphosphino) ethane, 1,3-bis (diphenylphosphino) propane, 1,4-bis (diphenylphosphino) butane, 2,2'-bis (diphenylphosphine) ) -1,1'-Binaphthyl, tricyclohexylphosphine, diphenylcyclohexylphosphine, dicyclohexylphenylphosphine, diphenylphosphinoferrocene, 2- (di-third-butylphosphino ) Biphenyl, tri (thirdbutyl) fluorene tetraphenylborate, and bis (thirdbutyl) methylfluorene tetraphenylborate. The organic phosphorus compound is preferably diadamantylbutylphosphine, tris (thirdbutyl) phosphine, tricyclohexylphosphine, or the like.

另外,也可以使用鈀化合物和有機磷化合物的複合體的二(三-第三丁基膦)鈀、二氯二(三苯基膦)鈀、二氯二(三環己基膦)鈀、二氯二(三-鄰甲苯基膦)鈀。In addition, bis (tri-third-butylphosphine) palladium, dichlorobis (triphenylphosphine) palladium, dichlorobis (tricyclohexylphosphine) palladium, di (tri-cyclohexylphosphine) palladium, di Chlorobis (tri-o-tolylphosphine) palladium.

作為鹼的具體例,可列舉下列具體例:第三丁醇鈉、第三戊醇鈉、碳酸銫、碳酸鈉、碳酸鉀及上述化合物的水溶液。鹼較佳為第三戊醇鈉、碳酸鈉或碳酸鉀等。Specific examples of the base include the following specific examples: sodium tert-butoxide, sodium tert-pentoxide, cesium carbonate, sodium carbonate, potassium carbonate, and an aqueous solution of the aforementioned compound. The base is preferably sodium tripentoxide, sodium carbonate, potassium carbonate, or the like.

作為亞磺酸鹽的具體例,可列舉下列具體例:甲烷亞磺酸鈉、苯亞磺酸鈉、對甲苯亞磺酸鈉。亞磺酸鹽較佳為苯亞磺酸鈉或對甲苯亞磺酸鈉。Specific examples of the sulfinate include the following specific examples: sodium methanesulfinate, sodium benzenesulfinate, and sodium p-toluenesulfinate. The sulfinate is preferably sodium benzenesulfinate or sodium p-toluenesulfinate.

在步驟(i)中,作為向溶劑中添加由式(a-1a)、式(a-1b)所示的化合物、鈀化合物、有機磷化合物及鹼的方法,可以使用下述方法(a)至方法(c)中的任一種: 方法(a):將由式(a-1a)、式(a-1b)所示的化合物、鈀化合物、有機磷化合物及鹼全部加入溶劑中,根據需要加入亞磺酸鹽,在15℃~溶劑回流溫度下反應而得。 方法(b):先將由式(a-1a)所示的化合物、鈀化合物、有機磷化合物及鹼加入溶劑中,根據需要加入亞磺酸鹽,在15~30℃下反應15分鐘~2小時之後,再加入由式(a-1b)所示的化合物,並在15℃~溶劑回流溫度下反應而得。 方法(c):首先,將鈀化合物、有機磷化合物加入溶劑中,在15~30℃下反應15分鐘~2小時;接著,加入由式(a-1a)所示的化合物及鹼,根據需要加入亞磺酸鹽;最後,加入由式(a-1b)所示的化合物,並在15℃~溶劑回流溫度下反應而得。In step (i), as a method of adding a compound represented by formula (a-1a), formula (a-1b), a palladium compound, an organic phosphorus compound, and a base to a solvent, the following method (a) can be used Any one of the methods (c): Method (a): All the compounds represented by formula (a-1a), formula (a-1b), palladium compound, organic phosphorus compound, and base are added to the solvent, and if necessary, The sulfinate is obtained by reacting at 15 ° C to the reflux temperature of the solvent. Method (b): first add the compound represented by formula (a-1a), palladium compound, organic phosphorus compound and base to the solvent, add sulfinate as needed, and react at 15-30 ° C for 15 minutes to 2 hours After that, the compound represented by the formula (a-1b) is added and reacted at a temperature of 15 ° C. to the reflux temperature of the solvent to obtain it. Method (c): First, add a palladium compound and an organic phosphorus compound to a solvent, and react at 15-30 ° C for 15 minutes to 2 hours; then, add a compound represented by formula (a-1a) and a base, as required Sulfinate is added; finally, the compound represented by formula (a-1b) is added and reacted at a temperature from 15 ° C to the reflux temperature of the solvent.

上述方法中,基於提升反應產率穩定性的觀點,方法(b)較方法(a)為佳;基於提升大量合成時的反應產率穩定性的觀點,方法(c)又較方法(b)為佳。Among the above methods, method (b) is better than method (a) from the viewpoint of improving the stability of the reaction yield; method (c) is also better than method (b) from the viewpoint of improving the stability of the reaction yield during large-scale synthesis. Better.

由步驟(i)所製得的由式(a-1c)所示的化合物可先經過管柱層析法、再結晶法或蒸餾法等公知方法先行精製純化之後,再進行步驟(ii)的反應,也可不經過精製純化的步驟,直接進行步驟(ii)的反應。The compound represented by formula (a-1c) obtained in step (i) can be first purified and purified by a known method such as column chromatography, recrystallization method or distillation method, and then carried out in step (ii). The reaction may be directly carried out in the step (ii) without going through the purification step.

基於式(a-1a)表示的化合物的使用量為1.0莫耳,由式(a-1b)表示的化合物的使用量為1.0至4.0莫耳,較佳為1.5至3.0莫耳。The use amount of the compound represented by the formula (a-1a) is 1.0 mol, and the use amount of the compound represented by the formula (a-1b) is 1.0 to 4.0 mol, preferably 1.5 to 3.0 mol.

基於式(a-1a)表示的化合物的使用量為1.0莫耳,鈀化合物的使用量為0.004至0.4莫耳,較佳為0.004至0.2莫耳。The use amount of the compound represented by the formula (a-1a) is 1.0 mol, and the use amount of the palladium compound is 0.004 to 0.4 mol, preferably 0.004 to 0.2 mol.

基於式(a-1a)表示的化合物的使用量為1.0莫耳,有機磷化合物的使用量為0.004至0.4莫耳,較佳為0.004至0.2莫耳。The use amount of the compound represented by the formula (a-1a) is 1.0 mol, and the use amount of the organic phosphorus compound is 0.004 to 0.4 mol, preferably 0.004 to 0.2 mol.

基於鈀化合物的使用量為1.0莫耳,有機磷化合物的使用量為1.0至8.0莫耳,較佳為1.0至2.0莫耳。The use amount of the palladium compound is 1.0 mol, and the use amount of the organic phosphorus compound is 1.0 to 8.0 mol, preferably 1.0 to 2.0 mol.

基於式(a-1a)表示的化合物的使用量為1.0莫耳,鹼的使用量為1.6至10.0莫耳,較佳為4.0至6.0莫耳。The use amount of the compound represented by the formula (a-1a) is 1.0 mol, and the use amount of the base is 1.6 to 10.0 mol, preferably 4.0 to 6.0 mol.

反應的溫度範圍為15℃至溶劑回流溫度,反應的時間為1小時至24小時。The reaction temperature ranges from 15 ° C to the reflux temperature of the solvent, and the reaction time ranges from 1 hour to 24 hours.

在步驟(ii)中,作為使由式(a-1c)所示的化合物中的羧酸基進行脫水環化反應的方法,可以列舉醋酸酐法、加熱脫水法等公知的方法。In step (ii), as a method of subjecting a carboxylic acid group in the compound represented by the formula (a-1c) to a dehydration cyclization reaction, a known method such as an acetic anhydride method and a thermal dehydration method may be mentioned.

具體來說,當式(a-1c)所示的化合物中的L3 全部表示為氫原子,如下述式(a-1d)所示的化合物時,可進行脫水環化反應而製得由式(a-1)所示的化合物:式(a-1d)中,L1 、L2 、a、b的定義與式(a-1)相同。Specifically, when all of L 3 in the compound represented by the formula (a-1c) is a hydrogen atom, as shown in the compound represented by the following formula (a-1d), a dehydration cyclization reaction can be performed to obtain the compound represented by the formula: Compound represented by (a-1): In the formula (a-1d), the definitions of L 1 , L 2 , a, and b are the same as those in the formula (a-1).

當式(a-1b)所示的化合物中的L3 部分為氫原子,其與式(a-1a)所示的化合物所形成式(a-1c)所示的化合物如下述式(a-1e)所示時,可進行分子內酯交換反應而製得由式(a-1)所示的化合物:式(a-1e)中,L1 、L2 、a、b的定義與式(a-1)相同。L4 各自獨立表示碳數為1至10的烷基,碳數為1至10的烷基,其中L4 所定義的碳數為1至10的烷基,與L3 所定義的碳數為1至10的烷基相同,在此不另贅述。When the L 3 moiety in the compound represented by the formula (a-1b) is a hydrogen atom, the compound represented by the formula (a-1c) formed with the compound represented by the formula (a-1a) is represented by the following formula (a- When shown in 1e), an intramolecular transesterification reaction can be performed to prepare a compound represented by formula (a-1): In the formula (a-1e), the definitions of L 1 , L 2 , a, and b are the same as those in the formula (a-1). L 4 each independently represents an alkyl group having 1 to 10 carbon atoms, an alkyl group having 1 to 10 carbon atoms, wherein the alkyl group having 1 to 10 carbon atoms defined by L 4 and the carbon number defined by L 3 are The alkyl groups of 1 to 10 are the same and will not be repeated here.

或者,當式(a-1c)所示的化合物中的L3 全部表示為L5 ,如下述式(a-1f)所示的化合物時,可在酸觸媒或鹼觸媒存在的情形下與水進行水解反應而生成由式(a-1d)所示的化合物之後,再進行脫水環化反應而製得由式(a-1)所示的化合物:式(a-1f)中,L1 、L2 、a、b的定義與式(a-1)相同。L5 各自獨立表示碳數為1至10的烷基,碳數為1至10的烷基,其中L5 所定義的碳數為1至10的烷基,與L3 所定義的碳數為1至10的烷基相同,在此不另贅述。Alternatively, when all of L 3 in the compound represented by the formula (a-1c) is represented by L 5 , as shown in the compound represented by the following formula (a-1f), it may be in the presence of an acid catalyst or a base catalyst. After the hydrolysis reaction with water to generate a compound represented by the formula (a-1d), a dehydration cyclization reaction is performed to obtain a compound represented by the formula (a-1): In the formula (a-1f), the definitions of L 1 , L 2 , a, and b are the same as those in the formula (a-1). L 5 each independently represents an alkyl group having 1 to 10 carbon atoms, an alkyl group having 1 to 10 carbon atoms, wherein the alkyl group having 1 to 10 carbon atoms defined by L 5 and the carbon number defined by L 3 are The alkyl groups of 1 to 10 are the same and will not be repeated here.

作為酸觸媒的具體例,可包含但不限於鹽酸、硝酸、硫酸、氟酸、草酸、磷酸、醋酸、三氟醋酸、蟻酸、多元羧酸或其酐、離子交換樹脂等。Specific examples of the acid catalyst include, but are not limited to, hydrochloric acid, nitric acid, sulfuric acid, fluoric acid, oxalic acid, phosphoric acid, acetic acid, trifluoroacetic acid, formic acid, polycarboxylic acids or their anhydrides, ion exchange resins, and the like.

作為鹼觸媒的具體例,可包含但不限於二乙胺、三乙胺、三丙胺、三丁胺、三戊胺、三己胺、三庚胺、三辛胺、二乙醇胺、三乙醇胺、氫氧化鈉、氫氧化鉀、含有胺基之烷氧基矽烷、離子交換樹脂等。Specific examples of the base catalyst may include, but are not limited to, diethylamine, triethylamine, tripropylamine, tributylamine, tripentylamine, trihexylamine, triheptylamine, trioctylamine, diethanolamine, triethanolamine, Sodium hydroxide, potassium hydroxide, amine-containing alkoxysilanes, ion exchange resins, etc.

由式(a-1)表示的化合物(a1)可列舉下述式(a-1-1)~式(a-1-17)的具體例,但並不限於這些具體例:式(a-1-1)式(a-1-2)式(a-1-3)式(a-1-4)式(a-1-5)式(a-1-6)式(a-1-7)式(a-1-8)式(a-1-9)式(a-1-10)式(a-1-11)式(a-1-12)式(a-1-13)式(a-1-14)式(a-1-15)式(a-1-16)式(a-1-17)Specific examples of the compound (a1) represented by the formula (a-1) include the following formulae (a-1-1) to (a-1-17), but are not limited to these specific examples: (A-1-1) (A-1-2) (A-1-3) (A-1-4) (A-1-5) (A-1-6) Formula (a-1-7) Formula (a-1-8) (A-1-9) Formula (a-1-10) (A-1-11) Formula (a-1-12) Formula (a-1-13) Formula (a-1-14) Formula (a-1-15) Formula (a-1-16) (A-1-17)

基於四羧酸二酐組份(a)的總莫耳數為100莫耳,由式(a-1)表示的化合物(a1)的使用量為2至20莫耳,較佳為3至17莫耳,更佳為4至15莫耳。The total mole number based on the tetracarboxylic dianhydride component (a) is 100 moles, and the amount of the compound (a1) represented by the formula (a-1) is 2 to 20 moles, preferably 3 to 17 Mol, more preferably 4 to 15 Mol.

若四羧酸二酐組份(a)中不含有由式(a-1)表示的化合物(a1)時,所製得的液晶配向膜的積蓄電荷消除性不佳。其他四羧酸二酐化合物( a2 When the compound (a1) represented by the formula (a-1) is not contained in the tetracarboxylic dianhydride component (a), the accumulated charge elimination property of the obtained liquid crystal alignment film is not good. Other tetracarboxylic dianhydride compounds ( a2 )

其他四羧酸二酐化合物(a2)包括脂肪族四羧酸二酐化合物、脂環族四羧酸二酐化合物、芳香族四羧酸二酐化合物、由式(a-2-1)至式(a-2-6)表示的四羧酸二酐化合物中的至少一種,或上述化合物的組合。Other tetracarboxylic dianhydride compounds (a2) include aliphatic tetracarboxylic dianhydride compounds, alicyclic tetracarboxylic dianhydride compounds, aromatic tetracarboxylic dianhydride compounds, from formula (a-2-1) to formula At least one of the tetracarboxylic dianhydride compounds represented by (a-2-6), or a combination of the aforementioned compounds.

脂肪族四羧酸二酐化合物的具體例可包括但不限於乙烷四羧酸二酐(ethane tetracarboxylic dianhydride)、丁烷四羧酸二酐(butane tetracarboxylic dianhydride)或上述化合物的組合。Specific examples of the aliphatic tetracarboxylic dianhydride compound may include, but are not limited to, ethane tetracarboxylic dianhydride, butane tetracarboxylic dianhydride, or a combination thereof.

脂環族四羧酸二酐化合物的具體例可包括但不限於1,2,3,4-環丁烷四羧酸二酐、1,2-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二氯-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、1,2,4,5-環己烷四羧酸二酐、3,3’,4,4’-二環己基四羧酸二酐、順式-3,7-二丁基環庚基-1,5-二烯-1,2,5,6-四羧酸二酐、2,3,5-三羧基環戊基醋酸二酐、二環[2.2.2]-辛-7-烯-2,3,5,6-四羧酸二酐或上述化合物的組合。Specific examples of the alicyclic tetracarboxylic dianhydride compound may include, but are not limited to, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2-dimethyl-1,2,3,4- Cyclobutane tetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,3-dichloro-1,2,3,4-cyclo Butane tetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,2,3,4-cyclopentane tetracarboxylic acid Acid dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 3,3 ', 4,4'-dicyclohexyltetracarboxylic dianhydride, cis-3,7-dibutyl Cycloheptyl-1,5-diene-1,2,5,6-tetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentylacetic dianhydride, bicyclo [2.2.2] -octane- 7-ene-2,3,5,6-tetracarboxylic dianhydride or a combination thereof.

芳香族四羧酸二酐化合物的具體例可包括但不限於3,4-二羧基-1,2,3,4-四氫萘-1-琥珀酸二酐、苯均四羧酸二酐、2,2',3,3'-二苯甲酮四羧酸二酐、3,3’,4,4’-二苯甲酮四羧酸二酐、3,3’,4,4’-聯苯碸四羧酸二酐、1,4,5,8-萘四羧酸二酐、2,3,6,7-萘四羧酸二酐、3,3’-4,4’-二苯基乙烷四羧酸二酐、3,3’,4,4’-二甲基二苯基矽烷四羧酸二酐、3,3’,4,4’-四苯基矽烷四羧酸二酐、1,2,3,4-呋喃四羧酸二酐、2,3,3',4'-二苯醚四羧酸二酐、3,3',4,4'-二苯醚四羧酸二酐、4,4’-雙(3,4-二羧基苯氧基)二苯硫醚二酐、2,3,3',4'-二苯硫醚四羧酸二酐、3,3',4,4'-二苯硫醚四羧酸二酐、4,4’-雙(3,4-二羧基苯氧基)二苯碸二酐、4,4’-雙(3,4-二羧基苯氧基)二苯丙烷二酐(4,4’-bis(3,4-dicarboxy phenoxy)diphenylpropane dianhydride)、3,3’,4,4’-全氟異亞丙基二苯二酸二酐、3,3’,4,4’-二苯基四羧酸二酐、雙(苯二酸)苯膦氧化物二酐、對-伸苯基-雙(三苯基苯二酸)二酐、間-伸苯基-雙(三苯基苯二酸)二酐、雙(三苯基苯二酸)-4,4’-二苯基醚二酐、雙(三苯基苯二酸)-4,4’-二苯基甲烷二酐、乙二醇-雙(脫水偏苯三酸酯)、丙二醇-雙(脫水偏苯三酸酯)、1,4-丁二醇-雙(脫水偏苯三酸酯)、1,6-己二醇-雙(脫水偏苯三酸酯)、1,8-辛二醇-雙(脫水偏苯三酸酯)、2,2-雙(4-羥苯基)丙烷-雙(脫水偏苯三酸酯)、2,3,4,5-四氫呋喃四羧酸二酐、1,3,3a,4,5,9b-六氫-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮{(1,3,3a,4,5,9b-hexahydro-5-(tetrahydro-2,5-dioxo- 3-furanyl)naphtho[1,2-c]furan-1,3-dione)}、1,3,3a,4,5,9b-六氫-5-甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5-乙基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-7-甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-7-乙基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-8-甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-8-乙基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5,8-二甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、5-(2,5-二側氧基四氫呋喃基)-3-甲基-3-環己烯-1,2-二羧酸二酐等芳香族四羧酸二酐化合物或上述化合物的組合。Specific examples of the aromatic tetracarboxylic dianhydride compound may include, but are not limited to, 3,4-dicarboxyl-1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride, pyromellitic dianhydride, 2,2 ', 3,3'-benzophenonetetracarboxylic dianhydride, 3,3', 4,4'-benzophenonetetracarboxylic dianhydride, 3,3 ', 4,4'- Biphenylphosphonium tetracarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 3,3'-4,4'-di Phenylethane tetracarboxylic dianhydride, 3,3 ', 4,4'-dimethyldiphenylsilane tetracarboxylic dianhydride, 3,3', 4,4'-tetraphenylsilane tetracarboxylic acid Dianhydride, 1,2,3,4-furantetracarboxylic dianhydride, 2,3,3 ', 4'-diphenyl ether tetracarboxylic dianhydride, 3,3', 4,4'-diphenyl ether Tetracarboxylic dianhydride, 4,4'-bis (3,4-dicarboxyphenoxy) diphenylsulfide dianhydride, 2,3,3 ', 4'-diphenylsulfide tetracarboxylic dianhydride, 3,3 ', 4,4'-diphenylsulfide tetracarboxylic dianhydride, 4,4'-bis (3,4-dicarboxyphenoxy) diphenylarsine dianhydride, 4,4'-bis ( 3,4-dicarboxyphenoxy) diphenylpropane dianhydride (4,4'-bis (3,4-dicarboxy phenoxy) diphenylpropane dianhydride), 3,3 ', 4,4'-perfluoroisopropylidene Diphthalic dianhydride, 3,3 ', 4,4'-diphenyltetracarboxylic dianhydride, bis Phthalic acid) phenylphosphine oxide dianhydride, p-phenylene-bis (triphenylphthalic acid) dianhydride, m-phenylene-bis (triphenylphthalic acid) dianhydride, bis (tris Phenylphthalic acid) -4,4'-diphenyl ether dianhydride, bis (triphenylphthalic acid) -4,4'-diphenylmethane dianhydride, ethylene glycol-bis (anhydrodehydrobenzene Triester), propylene glycol-bis (anhydrotrimellitate), 1,4-butanediol-bis (anhydrotrimellitate), 1,6-hexanediol-bis (anhydromellitate Esters), 1,8-octanediol-bis (anhydrotrimellitic acid esters), 2,2-bis (4-hydroxyphenyl) propane-bis (anhydrotrimellitic acid esters), 2,3,4 , 5-tetrahydrofuran tetracarboxylic dianhydride, 1,3,3a, 4,5,9b-hexahydro-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1 , 2-c] -furan-1,3-dione {(1,3,3a, 4,5,9b-hexahydro-5- (tetrahydro-2,5-dioxo- 3-furanyl) naphtho [1,2 -c] furan-1,3-dione)}, 1,3,3a, 4,5,9b-hexahydro-5-methyl-5- (tetrahydro-2,5-dioxo-3- Furyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-5-ethyl-5- (tetrahydro-2 , 5-dioxo-3-furyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3, 3a, 4,5,9b-hexahydro-7-methyl-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1 , 3-diketone, 1,3,3a, 4,5,9b-hexahydro-7-ethyl-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [ 1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-8-methyl-5- (tetrahydro-2,5-dioxo -3-furyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-8-ethyl-5- (tetra Hydrogen-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro -5,8-dimethyl-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 5 -An aromatic tetracarboxylic dianhydride compound such as (2,5-dioxotetrahydrofuranyl) -3-methyl-3-cyclohexene-1,2-dicarboxylic dianhydride or a combination thereof.

由式(a-2-1)至式(a-2-6)表示的四羧酸二酐化合物如下所示。式(a-2-1)式(a-2-2)式(a-2-3)式(a-2-4)式(a-2-5) 式(a-2-5)中,A1 表示含有芳香環的二價基團;r表示1至2的整數;A2 及A3 可為相同或不同,且可各自獨立表示-H或烷基。由式(a-2-5)表示的四羧酸二酐化合物的具體例包括由式(a-2-5-1)至式(a-2-5-3)表示的化合物中的至少一種。式(a-2-5-1)式(a-2-5-2)式(a-2-5-3)式(a-2-6) 式(a-2-6)中,A4 表示含有芳香環的二價基團;A5 及A6 可為相同或不同,且各自獨立表示-H或烷基。由式(a-2-6)表示的四羧酸二酐化合物較佳為由式(a-2-6-1)表示的化合物。式(a-2-6-1)The tetracarboxylic dianhydride compounds represented by the formula (a-2-1) to the formula (a-2-6) are shown below. (A-2-1) Formula (a-2-2) (A-2-3) (A-2-4) Formula (a-2-5) In formula (a-2-5), A 1 represents a divalent group containing an aromatic ring; r represents an integer of 1 to 2; A 2 and A 3 may be the same or different, and Each may independently represent -H or alkyl. Specific examples of the tetracarboxylic dianhydride compound represented by the formula (a-2-5) include at least one of compounds represented by the formula (a-2-5-1) to the formula (a-2-5-3) . Formula (a-2-5-1) Formula (a-2-5-2) Formula (a-2-5-3) Formula (a-2-6) In formula (a-2-6), A 4 represents a divalent group containing an aromatic ring; A 5 and A 6 may be the same or different, and each independently represents -H or an alkyl group. . The tetracarboxylic dianhydride compound represented by the formula (a-2-6) is preferably a compound represented by the formula (a-2-6-1). Formula (a-2-6-1)

較佳地,其他四羧酸二酐化合物(a2)包含但不限於1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、2,3,5-三羧基環戊基醋酸二酐、1,2,4,5-環己烷四羧酸二酐、3,4-二羧基-1,2,3,4-四氫萘-1-琥珀酸二酐、苯均四羧酸二酐、3,3’,4,4’-二苯甲酮四羧酸二酐以及3,3’,4,4’-聯苯碸四羧酸二酐。其他四羧酸二酐化合物(a2)可以單獨使用或者組合多種來使用。Preferably, the other tetracarboxylic dianhydride compounds (a2) include, but are not limited to, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic dianhydride Anhydride, 2,3,5-tricarboxycyclopentylacetic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 3,4-dicarboxy-1,2,3,4-tetracarboxylic acid Hydronaphthalene-1-succinic dianhydride, pyromellitic dianhydride, 3,3 ', 4,4'-benzophenonetetracarboxylic dianhydride, and 3,3', 4,4'-biphenyl Perylene tetracarboxylic dianhydride. The other tetracarboxylic dianhydride compounds (a2) may be used alone or in combination.

基於四羧酸二酐組份(a)的總莫耳數為100莫耳,其他四羧酸二酐化合物(a2)的使用量為80至98莫耳,較佳為83至97莫耳,更佳為85至96莫耳。The total mole number based on the tetracarboxylic dianhydride component (a) is 100 moles, and the amount of the other tetracarboxylic dianhydride compound (a2) is 80 to 98 moles, preferably 83 to 97 moles. More preferably, it is 85 to 96 mol.

基於二胺組份(b)的總莫耳數為100莫耳,四羧酸二酐組份(a)的使用量範圍較佳為20莫耳至200莫耳;更佳為30莫耳至120莫耳。二胺組份 b Based on the total mole number of the diamine component (b) is 100 moles, the amount of the tetracarboxylic dianhydride component (a) used is preferably from 20 moles to 200 moles; more preferably from 30 moles to 120 mol. Diamine component ( b )

二胺組份(b)包括由式(b-1)表示的二胺化合物(b1)、由式(b-2)表示的二胺化合物(b2)、以及其他二胺化合物(b3)。由式 (b-1) 表示的二胺化合物( b1 The diamine component (b) includes a diamine compound (b1) represented by formula (b-1), a diamine compound (b2) represented by formula (b-2), and other diamine compounds (b3). Diamine compound ( b1 ) represented by formula (b-1 )

由式(b-1)表示的二胺化合物(b1)如下所示:式(b-1) 式(b-1)中,R1 各自獨立表示氫原子、碳數為1至10的烷基、碳數為1至10的烷氧基、乙醯胺基、氟原子、氯原子或溴原子;R2 各自獨立表示碳數為1至3的烷基。 m各自獨立表示0至3的整數;n表示0至4的整數。The diamine compound (b1) represented by the formula (b-1) is shown below: Formula (b-1) In formula (b-1), R 1 each independently represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, an acetamido group, or a fluorine atom. , A chlorine atom or a bromine atom; R 2 each independently represents an alkyl group having 1 to 3 carbon atoms. m each independently represents an integer from 0 to 3; n represents an integer from 0 to 4.

在式(b-1)中,R1 較佳為各自獨立表示氫原子、碳數為1至10的烷基、碳數為1至10的烷氧基或乙醯胺基。In the formula (b-1), R 1 is each preferably a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, or an acetamido group.

由式(b-1)表示的二胺化合物(b1)的具體例包括但不限於由式(b-1-1)至式(b-1-28)表示的二胺化合物中的至少一種。式(b-1-1)式(b-1-2)式(b-1-3)式(b-1-4)式(b-1-5)式(b-1-6)式(b-1-7)式(b-1-8)式(b-1-9)式(b-1-10)式(b-1-11)式(b-1-12)式(b-1-13)式(b-1-14)式(b-1-15)式(b-1-16)式(b-1-17)式(b-1-18)式(b-1-19)式(b-1-20)式(b-1-21)式(b-1-22)式(b-1-23)式(b-1-24)式(b-1-25)式(b-1-26)式(b-1-27)式(b-1-28)Specific examples of the diamine compound (b1) represented by the formula (b-1) include, but are not limited to, at least one of the diamine compounds represented by the formula (b-1-1) to the formula (b-1-28). Formula (b-1-1) (B-1-2) Formula (b-1-3) Formula (b-1-4) Formula (b-1-5) Formula (b-1-6) Formula (b-1-7) Formula (b-1-8) Formula (b-1-9) Formula (b-1-10) Formula (b-1-11) Formula (b-1-12) Formula (b-1-13) Formula (b-1-14) Formula (b-1-15) Formula (b-1-16) (B-1-17) Formula (b-1-18) (B-1-19) Formula (b-1-20) Formula (b-1-21) Formula (b-1-22) Formula (b-1-23) Formula (b-1-24) Formula (b-1-25) (B-1-26) (B-1-27) Formula (b-1-28)

由式(b-1)表示的二胺化合物(b1)可以單獨使用或者組合多種來使用。The diamine compound (b1) represented by the formula (b-1) may be used alone or in combination.

基於二胺組份(b)的總莫耳數為100莫耳,由式(b-1)表示的二胺化合物(b1)的使用量為2至20莫耳,較佳為3至17莫耳,更佳為4至15莫耳。The total mole number based on the diamine component (b) is 100 moles, and the amount of the diamine compound (b1) represented by the formula (b-1) is 2 to 20 moles, preferably 3 to 17 moles. Ears, more preferably 4 to 15 moles.

若二胺組份(b)中含有由式(b-1)表示的二胺化合物(b1)時,所製得的液晶配向膜具有更佳的積蓄電荷消除性。由式 (b-2) 表示的二胺化合物( b2 When the diamine component (b) contains the diamine compound (b1) represented by the formula (b-1), the obtained liquid crystal alignment film has better accumulative charge elimination properties. Diamine compound ( b2 ) represented by formula (b-2 )

由式(b-2)表示的二胺化合物(b2)如下所示:式(b-2) 式(b-2)中,h表示1至12的整數。The diamine compound (b2) represented by the formula (b-2) is shown below: Formula (b-2) In Formula (b-2), h represents an integer of 1-12.

具體來說,由式(b-2)表示的二胺化合物(b2)包含具有如下述式(b-2-1)至式(b-2-3)所示結構的二胺化合物:式(b-2-1)式(b-2-2)式(b-2-3) 式(b-2-1)至式(b-2-3)中,h表示1至12的整數。Specifically, the diamine compound (b2) represented by the formula (b-2) includes a diamine compound having a structure represented by the following formula (b-2-1) to formula (b-2-3): Formula (b-2-1) Formula (b-2-2) Formula (b-2-3) In formula (b-2-1) to formula (b-2-3), h represents an integer of 1 to 12.

前述具有如式(b-2-1)所示結構的二胺化合物之具體例可為二(4-胺基苯氧基)甲烷、1,2-二(4-胺基苯氧基)乙烷、1,3-二(4-胺基苯氧基)丙烷、1,4-二(4-胺基苯氧基)丁烷、1,5-二(4-胺基苯氧基)戊烷、1,6-二(4-胺基苯氧基)己烷、1,7-二(4-胺基苯氧基)庚烷、1,8-二(4-胺基苯氧基)辛烷、1,9-二(4-胺基苯氧基)壬烷、1,10-二(4-胺基苯氧基)癸烷或上述化合物之任意組合。Specific examples of the diamine compound having the structure represented by the formula (b-2-1) include bis (4-aminophenoxy) methane and 1,2-bis (4-aminophenoxy) ethyl. Alkane, 1,3-bis (4-aminophenoxy) propane, 1,4-bis (4-aminophenoxy) butane, 1,5-bis (4-aminophenoxy) pentane Alkane, 1,6-bis (4-aminophenoxy) hexane, 1,7-bis (4-aminophenoxy) heptane, 1,8-bis (4-aminophenoxy) Octane, 1,9-bis (4-aminophenoxy) nonane, 1,10-bis (4-aminophenoxy) decane, or any combination thereof.

前述具有如式(b-2-2)所示結構的二胺化合物之具體例可為二(2-胺基苯氧基)甲烷、1,2-二(2-胺基苯氧基)乙烷、1,3-二(2-胺基苯氧基)丙烷、1,4-二(2-胺基苯氧基)丁烷、1,5-二(2-胺基苯氧基)戊烷、1,6-二(2-胺基苯氧基)己烷、1,7-二(2-胺基苯氧基)庚烷、1,8-二(2-胺基苯氧基)辛烷、1,9-二(2-胺基苯氧基)壬烷、1,10-二(2-胺基苯氧基)癸烷或上述化合物之任意組合。Specific examples of the diamine compound having the structure represented by the formula (b-2-2) include bis (2-aminophenoxy) methane and 1,2-bis (2-aminophenoxy) ethyl. Alkane, 1,3-bis (2-aminophenoxy) propane, 1,4-bis (2-aminophenoxy) butane, 1,5-bis (2-aminophenoxy) pentane Alkane, 1,6-bis (2-aminophenoxy) hexane, 1,7-bis (2-aminophenoxy) heptane, 1,8-bis (2-aminophenoxy) Octane, 1,9-bis (2-aminophenoxy) nonane, 1,10-bis (2-aminophenoxy) decane, or any combination thereof.

前述具有如式(b-2-3)所示結構的二胺化合物之具體例可為二(3-胺基苯氧基)甲烷、1,2-二(3-胺基苯氧基)乙烷、1,3-二(3-胺基苯氧基)丙烷、1,4-二(3-胺基苯氧基)丁烷、1,5-二(3-胺基苯氧基)戊烷、1,6-二(3-胺基苯氧基)己烷、1,7-二(3-胺基苯氧基)庚烷、1,8-二(3-胺基苯氧基)辛烷、1,9-二(3-胺基苯氧基)壬烷、1,10-二(3-胺基苯氧基)癸烷或上述化合物之任意組合。Specific examples of the diamine compound having the structure represented by the formula (b-2-3) include bis (3-aminophenoxy) methane and 1,2-bis (3-aminophenoxy) ethyl. Alkane, 1,3-bis (3-aminophenoxy) propane, 1,4-bis (3-aminophenoxy) butane, 1,5-bis (3-aminophenoxy) pentane Alkane, 1,6-bis (3-aminophenoxy) hexane, 1,7-bis (3-aminophenoxy) heptane, 1,8-bis (3-aminophenoxy) Octane, 1,9-bis (3-aminophenoxy) nonane, 1,10-bis (3-aminophenoxy) decane, or any combination thereof.

較佳地,由式(b-2)表示的二胺化合物(b2)之具體例可為1,3-二(4-胺基苯氧基)丙烷、1,4-二(4-胺基苯氧基)丁烷、1,5-二(4-胺基苯氧基)戊烷、1,6-二(4-胺基苯氧基)己烷、1,7-二(4-胺基苯氧基)庚烷、1,8-二(4-胺基苯氧基)辛烷、1,3-二(2-胺基苯氧基)丙烷、1,4-二(2-胺基苯氧基)丁烷、1,5-二(2-胺基苯氧基)戊烷、1,6-二(2-胺基苯氧基)己烷、1,7-二(2-胺基苯氧基)庚烷、1,8-二(2-胺基苯氧基)辛烷、1,3-二(3-胺基苯氧基)丙烷、1,4-二(3-胺基苯氧基)丁烷、1,5-二(3-胺基苯氧基)戊烷、1,6-二(3-胺基苯氧基)己烷、1,7-二(3-胺基苯氧基)庚烷或1,8-二(3-胺基苯氧基)辛烷等。Preferably, specific examples of the diamine compound (b2) represented by the formula (b-2) may be 1,3-bis (4-aminophenoxy) propane, 1,4-bis (4-amino group) Phenoxy) butane, 1,5-bis (4-aminophenoxy) pentane, 1,6-bis (4-aminophenoxy) hexane, 1,7-bis (4-amine Phenylphenoxy) heptane, 1,8-bis (4-aminophenoxy) octane, 1,3-bis (2-aminophenoxy) propane, 1,4-bis (2-amine Phenylphenoxy) butane, 1,5-bis (2-aminophenoxy) pentane, 1,6-bis (2-aminophenoxy) hexane, 1,7-bis (2- Aminophenoxy) heptane, 1,8-bis (2-aminophenoxy) octane, 1,3-bis (3-aminophenoxy) propane, 1,4-bis (3- Aminophenoxy) butane, 1,5-bis (3-aminophenoxy) pentane, 1,6-bis (3-aminophenoxy) hexane, 1,7-bis (3 -Aminophenoxy) heptane or 1,8-bis (3-aminophenoxy) octane and the like.

基於二胺組份(b)的總莫耳數為100莫耳,由式(b-2)表示的二胺化合物(b2)的使用量為10至80莫耳,較佳為15至75莫耳,更佳為20至70莫耳。The total mole number based on the diamine component (b) is 100 moles, and the amount of the diamine compound (b2) represented by the formula (b-2) is 10 to 80 moles, preferably 15 to 75 moles. Ears, more preferably 20 to 70 moles.

若二胺組份(b)中含有由式(b-2)表示的二胺化合物(b2)時,所製得的液晶配向膜具有更佳的積蓄電荷消除性。其他二胺化合物( b3 When the diamine component (b) contains a diamine compound (b2) represented by the formula (b-2), the liquid crystal alignment film obtained has better charge accumulation eliminating ability. Other diamine compounds ( b3 )

其他二胺化合物(b3)包括脂肪族二胺化合物、脂環族二胺化合物、芳香族二胺化合物、具有式(b-3-1)至式(b-3-29)所示結構的二胺化合物、或其組合。Other diamine compounds (b3) include aliphatic diamine compounds, alicyclic diamine compounds, aromatic diamine compounds, and diamines having structures represented by formulae (b-3-1) to (b-3-29). An amine compound, or a combination thereof.

脂肪族二胺化合物的具體例包括但不限於1,2-二胺基乙烷、1,3-二胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊烷、1,6-二胺基己烷、1,7-二胺基庚烷、1,8-二胺基辛烷、1,9-二胺基壬烷、1,10-二胺基癸烷、4,4’-二胺基庚烷、1,3-二胺基-2,2-二甲基丙烷、1,6-二胺基-2,5-二甲基己烷、1,7-二胺基-2,5-二甲基庚烷、1,7-二胺基-4,4-二甲基庚烷、1,7-二胺基-3-甲基庚烷、1,9-二胺基-5-甲基壬烷、2,11-二胺基十二烷、1,12-二胺基十八烷、1,2-雙(3-胺基丙氧基)乙烷,或上述化合物的組合。Specific examples of the aliphatic diamine compound include, but are not limited to, 1,2-diaminoethane, 1,3-diaminopropane, 1,4-diaminobutane, 1,5-diaminopentane , 1,6-diaminohexane, 1,7-diaminoheptane, 1,8-diaminooctane, 1,9-diaminononane, 1,10-diaminodecane , 4,4'-diaminoheptane, 1,3-diamino-2,2-dimethylpropane, 1,6-diamino-2,5-dimethylhexane, 1,7 -Diamino-2,5-dimethylheptane, 1,7-diamino-4,4-dimethylheptane, 1,7-diamino-3-methylheptane, 1, 9-diamino-5-methylnonane, 2,11-diaminododecane, 1,12-diaminooctadecane, 1,2-bis (3-aminopropoxy) ethyl Alkane, or a combination of the above.

脂環族二胺化合物的具體例包括但不限於4,4’-二胺基二環己基甲烷、4,4’-二胺基-3,3’-二甲基二環己基胺、1,3-二胺基環己烷、1,4-二胺基環己烷、異佛爾酮二胺、四氫二環戊二烯二胺、三環[6.2.1.02,7 ]-十一碳烯二甲基二胺、4,4’-亞甲基雙(環己基胺),或上述化合物的組合。Specific examples of the alicyclic diamine compound include, but are not limited to, 4,4'-diaminodicyclohexylmethane, 4,4'-diamino-3,3'-dimethyldicyclohexylamine, 1, 3-diaminocyclohexane, 1,4-diaminocyclohexane, isophorone diamine, tetrahydrodicyclopentadiene diamine, tricyclo [6.2.1.0 2,7 ] -unda Carbenedimethyldiamine, 4,4'-methylenebis (cyclohexylamine), or a combination thereof.

芳香族二胺化合物的具體例包括但不限於4,4’-二胺基二苯基甲烷、4,4’-二胺基二苯基乙烷、4,4’-二胺基二苯基碸、4,4’-二胺基苯甲醯苯胺、4,4’-二胺基二苯基醚、3,4’-二胺基二苯基醚、1,5-二胺基萘、5-胺基-1-(4’-胺基苯基)-1,3,3-三甲基氫茚、6-胺基-1-(4’-胺基苯基)-1,3,3-三甲基氫茚、六氫-4,7-甲橋伸氫茚基二亞甲基二胺、3,3’-二胺基二苯甲酮、3,4’-二胺基二苯甲酮、4,4’-二胺基二苯甲酮、2,2-雙[4-(4-胺基苯氧基)苯基]丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2-雙(4-胺基苯基)六氟丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]碸、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,3-雙(3-胺基苯氧基)苯、9,9-雙(4-胺基苯基)-10-氫蒽、9,10-雙(4-胺基苯基)蒽[9,10-bis(4-aminophenyl) anthracene]、2,7-二胺基茀、9,9-雙(4-胺基苯基)茀、4,4’-亞甲基-雙(2-氯苯胺)、4,4’-(對-伸苯基異亞丙基)雙苯胺、4,4’-(間-伸苯基異亞丙基)雙苯胺、2,2’-雙[4-(4-胺基-2-三氟甲基苯氧基)苯基]六氟丙烷、4,4’-雙[(4-胺基-2-三氟甲基)苯氧基]-八氟聯苯、5-[4-(4-正戊烷基環己基)環己基]苯基-亞甲基-1,3-二胺基苯{5-[4-(4-n-pentylcyclohexyl)cyclohexyl] phenylmethylene-1,3-diaminobenzene}、1,1-雙[4-(4-胺基苯氧基)苯基]-4-(4-乙基苯基)環己烷{1,1-bis[4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl) cyclohexane},或上述化合物的組合。Specific examples of the aromatic diamine compound include, but are not limited to, 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylethane, 4,4'-diaminodiphenyl Hydrazone, 4,4'-diaminobenzylanilide, 4,4'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 1,5-diaminonaphthalene, 5-amino-1- (4'-aminophenyl) -1,3,3-trimethylhydroindene, 6-amino-1- (4'-aminophenyl) -1,3, 3-trimethylhydroindene, hexahydro-4,7-methyl bridged indenyl dimethylene diamine, 3,3'-diamino benzophenone, 3,4'-diamine di Benzophenone, 4,4'-diaminobenzophenone, 2,2-bis [4- (4-aminophenoxy) phenyl] propane, 2,2-bis [4- (4- Aminophenoxy) phenyl] hexafluoropropane, 2,2-bis (4-aminophenyl) hexafluoropropane, 2,2-bis [4- (4-aminophenoxy) phenyl] Hydrazone, 1,4-bis (4-aminophenoxy) benzene, 1,3-bis (4-aminophenoxy) benzene, 1,3-bis (3-aminophenoxy) benzene, 9,9-bis (4-aminophenyl) -10-hydroanthracene, 9,10-bis (4-aminophenyl) anthracene [9,10-bis (4-aminophenyl) anthracene], 2,7 -Diaminofluorene, 9,9-bis (4-aminophenyl) fluorene, 4,4 -Methylene-bis (2-chloroaniline), 4,4 '-(p-phenylene isopropylidene) bisaniline, 4,4'-(m-phenylene isopropylidene) bisaniline , 2,2'-bis [4- (4-amino-2-trifluoromethylphenoxy) phenyl] hexafluoropropane, 4,4'-bis [(4-amino-2-trifluoro Methyl) phenoxy] -octafluorobiphenyl, 5- [4- (4-n-pentylcyclohexyl) cyclohexyl] phenyl-methylene-1,3-diaminobenzene {5- [ 4- (4-n-pentylcyclohexyl) cyclohexyl] phenylmethylene-1,3-diaminobenzene}, 1,1-bis [4- (4-aminophenoxy) phenyl] -4- (4-ethylphenyl ) Cyclohexane {1,1-bis [4- (4-aminophenoxy) phenyl] -4- (4-ethylphenyl) cyclohexane}, or a combination thereof.

具有式(b-3-1)至式(b-3-29)所示結構的二胺化合物如下所示。式(b-3-1) 式(b-3-1)中,B1 表示,或;B2 表示具有甾(膽固醇(steroid))骨架的基、三氟甲基、氟基、碳數為2至30的烷基、或衍生自吡啶、嘧啶、三嗪、哌啶或哌嗪等含氮原子環狀結構的一價基團。The diamine compounds having structures represented by the formulae (b-3-1) to (b-3-29) are shown below. Formula (b-3-1) In formula (b-3-1), B 1 represents , , , , ,or ; B 2 represents a group having a steroid (cholesterol) skeleton, a trifluoromethyl group, a fluoro group, an alkyl group having 2 to 30 carbon atoms, or derived from pyridine, pyrimidine, triazine, piperidine, or piperazine, etc. A monovalent group containing a nitrogen atom ring structure.

由式(b-3-1)表示的化合物的具體例包括但不限於2,4-二胺基苯基甲酸乙酯(2,4-diaminophenyl ethyl formate)、3,5-二胺基苯基甲酸乙酯(3,5-diaminophenyl ethyl formate)、2,4-二胺基苯基甲酸丙酯(2,4-diaminophenyl propyl formate)、3,5-二胺基苯基甲酸丙酯(3,5- diaminophenyl propyl formate)、1-十二烷氧基-2,4-二胺基苯(1-dodecoxy-2,4-diaminobenzene)、1-十六烷氧基-2,4-二胺基苯(1-hexadecoxy-2,4-diaminobenzene)、1-十八烷氧基-2,4-二胺基苯(1-octadecoxy-2,4-diaminobenzene)、由式(b-3-1-1)至式(b-3-1-6)表示的化合物中的至少其中一種,或上述化合物的組合。Specific examples of the compound represented by the formula (b-3-1) include, but are not limited to, 2,4-diaminophenyl ethyl formate, 3,5-diaminophenyl Ethyl 3,5-diaminophenyl ethyl formate, 2,4-diaminophenyl propyl formate, 3,5-diaminophenyl propyl formate, 5-diaminophenyl propyl formate), 1-dodecoxy-2,4-diaminobenzene, 1-dodecoxy-2,4-diaminobenzene Benzene (1-hexadecoxy-2,4-diaminobenzene), 1-octadecoxy-2,4-diaminobenzene (1-octadecoxy-2,4-diaminobenzene), by the formula (b-3-1- 1) At least one of the compounds represented by the formula (b-3-1-6), or a combination of the aforementioned compounds.

由式(b-3-1-1)至式(b-3-1-6)表示的化合物如下所示。式(b-3-1-1)式(b-3-1-2)式(b-3-1-3)式(b-3-1-4)式(b-3-1-5)式(b-3-1-6)The compounds represented by the formula (b-3-1-1) to the formula (b-3-1-6) are shown below. Formula (b-3-1-1) Formula (b-3-1-2) Formula (b-3-1-3) Formula (b-3-1-4) Formula (b-3-1-5) Formula (b-3-1-6)

式(b-3-2) 式(b-3-2)中,B1 與式(b-3-1)中的B1 相同,B3 及B4 各自獨立表示二價脂肪族環、二價芳香族環或二價雜環基團;B5 表示碳數為3至18的烷基、碳數為3至18的烷氧基、碳數為1至5的氟烷基、碳數為1至5的氟烷氧基、氰基或鹵素原子。 In the formula (b-3-2) of formula (b-3-2), and B 1 in the formula (b-3-1) B same as 1, B 3 and B 4 each independently represents a divalent aliphatic ring, two Valent aromatic ring or divalent heterocyclic group; B 5 represents an alkyl group having 3 to 18 carbon atoms, an alkoxy group having 3 to 18 carbon atoms, a fluoroalkyl group having 1 to 5 carbon atoms, and a carbon number of 1 to 5 fluoroalkoxy, cyano or halogen atoms.

由式(b-3-2)表示的化合物的具體例包括由下列式(b-3-2-1)至式(b-3-2-13)表示的化合物中的至少其中一種:式(b-3-2-1)式(b-3-2-2)式(b-3-2-3)式(b-3-2-4)式(b-3-2-5)式(b-3-2-6)式(b-3-2-7)式(b-3-2-8)式(b-3-2-9)式(b-3-2-10)式(b-3-2-11)式(b-3-2-12)式(b-3-2-13) 式(b-3-2-1)至式(b-3-2-13)中,s表示3至12的整數。Specific examples of the compound represented by the formula (b-3-2) include at least one of compounds represented by the following formula (b-3-2-1) to the formula (b-3-2-13): Formula (b-3-2-1) Formula (b-3-2-2) Formula (b-3-2-3) Formula (b-3-2-4) Formula (b-3-2-5) Formula (b-3-2-6) Formula (b-3-2-7) Formula (b-3-2-8) Formula (b-3-2-9) Formula (b-3-2-10) Formula (b-3-2-11) Formula (b-3-2-12) Formula (b-3-2-13) In formula (b-3-2-1) to formula (b-3-2-13), s represents an integer of 3 to 12.

式(b-3-3) 式(b-3-3)中,B6 各自獨立表示氫原子、碳數為1至5的醯基、碳數為1至5的烷基、碳數為1至5的烷氧基或鹵素原子,且每個重複單元中的B6 可為相同或不同;u表示1至3的整數。 Formula (b-3-3) In formula (b-3-3), B 6 each independently represents a hydrogen atom, a fluorenyl group having 1 to 5 carbon atoms, an alkyl group having 1 to 5 carbon atoms, and a carbon number of 1 To 5 alkoxy or halogen atoms, and B 6 in each repeating unit may be the same or different; u represents an integer of 1 to 3.

由式(b-3-3)表示的化合物的具體例包括當u為1時:對-二胺苯、間-二胺苯、鄰-二胺苯或2,5-二胺基甲苯等;當u為2時:4,4’-二胺基聯苯、2,2’-二甲基-4,4’-二胺基聯苯、3,3’-二甲基-4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、2,2’-二氯-4,4’-二胺基聯苯、3,3’-二氯-4,4’-二胺基聯苯、2,2’,5,5’-四氯-4,4’-二胺基聯苯、2,2’-二氯-4,4’-二胺基-5,5’-二甲氧基聯苯或4,4’-二胺基-2,2’-雙(三氟甲基)聯苯等;或當u為3時:1,4-雙(4’-胺基苯基)苯等。Specific examples of the compound represented by the formula (b-3-3) include when u is 1: p-diaminebenzene, m-diaminebenzene, o-diaminebenzene, 2,5-diaminotoluene, and the like; When u is 2: 4,4'-diaminobiphenyl, 2,2'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethyl-4,4 ' -Diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 2,2'-dichloro-4,4'-diaminobiphenyl, 3,3 '-Dichloro-4,4'-diaminobiphenyl, 2,2', 5,5'-tetrachloro-4,4'-diaminobiphenyl, 2,2'-dichloro-4, 4'-diamino-5,5'-dimethoxybiphenyl or 4,4'-diamino-2,2'-bis (trifluoromethyl) biphenyl, etc .; or when u is 3 : 1,4-bis (4'-aminophenyl) benzene and the like.

由式(b-3-3)表示的化合物的具體例較佳為包括對-二胺苯、2,5-二胺基甲苯、4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、1,4-雙(4’-胺基苯基)苯或上述化合物的組合。Specific examples of the compound represented by the formula (b-3-3) include preferably p-diaminebenzene, 2,5-diaminotoluene, 4,4'-diaminobiphenyl, 3,3'- Dimethoxy-4,4'-diaminobiphenyl, 1,4-bis (4'-aminophenyl) benzene or a combination thereof.

式(b-3-4) 式(b-3-4)中,w表示1至5的整數。由式(b-3-4)表示的化合物較佳為4,4’-二胺基-二苯基硫醚。 Formula (b-3-4) In Formula (b-3-4), w represents an integer of 1 to 5. The compound represented by the formula (b-3-4) is preferably 4,4'-diamino-diphenylsulfide.

式(b-3-5) 式(b-3-5)中,B7 及B9 各自獨立表示二價有機基團,且B7 及B9 可為相同或不同;B8 表示衍生自吡啶、嘧啶、三嗪、哌啶或哌嗪等含氮原子的環狀結構的二價基團。 Formula (b-3-5) In formula (b-3-5), B 7 and B 9 each independently represent a divalent organic group, and B 7 and B 9 may be the same or different; B 8 represents a derivative derived from pyridine , A divalent group having a cyclic structure containing a nitrogen atom such as pyrimidine, triazine, piperidine, or piperazine.

式(b-3-6) 式(b-3-6)中,B10 、B11 、B12 及B13 各自獨立表示碳數為1至12的烴基,且B10 、B11 、B12 及B13 可為相同或不同;x1各自獨立表示1至3的整數;x2表示1至20的整數。 Formula (b-3-6) In formula (b-3-6), B 10 , B 11 , B 12, and B 13 each independently represent a hydrocarbon group having 1 to 12 carbon atoms, and B 10 , B 11 , B 12 And B 13 may be the same or different; x1 each independently represents an integer of 1 to 3; x2 represents an integer of 1 to 20.

式(b-3-7) 式(b-3-7)中,B14 表示氧原子或伸環己烷基;B15 表示亞甲基;B16 表示伸苯基或伸環己烷基;B17 表示氫原子或庚基。 Formula (b-3-7) In formula (b-3-7), B 14 represents an oxygen atom or a cyclohexyl group; B 15 represents a methylene group; B 16 represents a phenylene group or a cyclohexane group; B 17 represents a hydrogen atom or a heptyl group.

由式(b-3-7)表示的化合物的具體例包括由式(b-3-7-1)表示的化合物、由式(b-3-7-2)表示的化合物或上述化合物的組合:式(b-3-7-1)式(b-3-7-2)Specific examples of the compound represented by the formula (b-3-7) include a compound represented by the formula (b-3-7-1), a compound represented by the formula (b-3-7-2), or a combination thereof : Formula (b-3-7-1) Formula (b-3-7-2)

由式(b-3-8)至式(b-3-29)表示的化合物如下所示。式(b-3-8)式(b-3-9)式(b-3-10)式(b-3-11)式(b-3-12)式(b-3-13)式(b-3-14)式(b-3-15)式(b-3-16)式(b-3-17)式(b-3-18)式(b-3-19)式(b-3-20)式(b-3-21)式(b-3-22)式(b-3-23)式(b-3-24)式(b-3-25)式(b-3-26)式(b-3-27)式(b-3-28)式(b-3-29) 式(b-3-16)至式(b-3-24)中,B18 較佳為表示碳數為1至10的烷基或碳數為1至10的烷氧基;B19 較佳為表示氫原子、碳數為1至10的烷基或碳數為1至10的烷氧基。The compounds represented by the formula (b-3-8) to the formula (b-3-29) are shown below. Formula (b-3-8) Formula (b-3-9) Formula (b-3-10) Formula (b-3-11) Formula (b-3-12) Formula (b-3-13) Formula (b-3-14) Formula (b-3-15) Formula (b-3-16) Formula (b-3-17) Formula (b-3-18) Formula (b-3-19) Formula (b-3-20) Formula (b-3-21) Formula (b-3-22) Formula (b-3-23) Formula (b-3-24) Formula (b-3-25) Formula (b-3-26) Formula (b-3-27) Formula (b-3-28) Formula (b-3-29) In formulas (b-3-16) to (b-3-24), B 18 is preferably an alkyl group having 1 to 10 carbon atoms or 1 to 10 carbon atoms. Alkoxy; B 19 preferably represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, or an alkoxy group having 1 to 10 carbon atoms.

其他二胺化合物(b3)可單獨使用或組合多種來使用。The other diamine compounds (b3) can be used alone or in combination.

其他二胺化合物(b3)的具體例較佳為包括但不限於1,2-二胺基乙烷、4,4’-二胺基二環己基甲烷、4,4’-二胺基二苯基甲烷、4,4’-二胺基二苯基醚、5-[4-(4-正戊烷基環己基)環己基]苯基亞甲基-1,3-二胺基苯、1,1-雙[4-(4-胺基苯氧基)苯基]-4-(4-乙基苯基)環己烷、2,4-二胺基苯基甲酸乙酯、對-二胺苯、間-二胺苯、鄰-二胺苯、由式(b-3-1-1)表示的化合物、由式(b-3-1-2)表示的化合物、由式(b-3-1-5)表示的化合物、由式(b-3-2-1)表示的化合物、由式(b-3-2-11)表示的化合物、由式(b-3-7-1)表示的化合物、由式(b-3-25)表示的化合物、由式(b-3-28)表示的化合物,或上述化合物的組合。Specific examples of other diamine compounds (b3) preferably include, but are not limited to, 1,2-diaminoethane, 4,4'-diaminodicyclohexylmethane, and 4,4'-diaminodiphenyl Methane, 4,4'-diaminodiphenyl ether, 5- [4- (4-n-pentylcyclohexyl) cyclohexyl] phenylmethylene-1,3-diaminobenzene, 1 , 1-bis [4- (4-aminophenoxy) phenyl] -4- (4-ethylphenyl) cyclohexane, ethyl 2,4-diaminophenylcarboxylate, p-di Amine benzene, m-diamine benzene, o-diamine benzene, compound represented by formula (b-3-1-1), compound represented by formula (b-3-1-2), 3-1-5), a compound represented by formula (b-3-2-1), a compound represented by formula (b-3-2-11), and a compound represented by formula (b-3-7-1 A compound represented by), a compound represented by formula (b-3-25), a compound represented by formula (b-3-28), or a combination thereof.

基於二胺組份(b)的總莫耳數為100莫耳,其他二胺化合物(b3)的使用量為0至88莫耳,較佳為5至85莫耳,更佳為10至80莫耳。製備聚合物( A )的方法 The total mole number based on the diamine component (b) is 100 moles, and the amount of other diamine compounds (b3) used is 0 to 88 moles, preferably 5 to 85 moles, and more preferably 10 to 80 Mor. Method for preparing polymer ( A )

聚合物(A)可包括聚醯胺酸及聚醯亞胺中的至少一者。另外,聚合物(A)可更包括聚醯亞胺系嵌段共聚合物。以下進一步說明上述各種聚合物的製備方法。製備聚醯胺酸的方法 The polymer (A) may include at least one of a polyamidic acid and a polyimide. The polymer (A) may further include a polyfluorene-based block copolymer. The methods for preparing the various polymers described above are further described below. Method for preparing polyamic acid

製備聚醯胺酸的方法為先將混合物溶解於溶劑中,其中混合物包括四羧酸二酐組份(a)與二胺組份(b),並於0℃至100℃的溫度下進行聚縮合反應。反應1小時至24小時後,以蒸發器對反應溶液進行減壓蒸餾,即可得到聚醯胺酸。或者,將反應溶液倒入大量的貧溶劑中,以得到析出物。接著,以減壓乾燥的方式乾燥析出物,即可得到聚醯胺酸。The method for preparing polyamic acid is to first dissolve the mixture in a solvent, wherein the mixture includes a tetracarboxylic dianhydride component (a) and a diamine component (b), and polymerize at a temperature of 0 ° C to 100 ° C. Condensation reaction. After reacting for 1 hour to 24 hours, the reaction solution is distilled under reduced pressure using an evaporator to obtain polyamic acid. Alternatively, the reaction solution is poured into a large amount of a lean solvent to obtain a precipitate. Then, the precipitate is dried under reduced pressure to obtain polyamic acid.

基於二胺組份(b)的總莫耳數為100莫耳,四羧酸二酐組份(a)的使用量為20莫耳至200莫耳;更佳地,四羧酸二酐組份(a)的使用量為30莫耳至120莫耳。Based on the total mole number of the diamine component (b) is 100 moles, and the amount of the tetracarboxylic dianhydride component (a) is 20 to 200 moles; more preferably, the tetracarboxylic dianhydride group Part (a) is used in an amount of 30 to 120 mol.

用於聚縮合反應中的溶劑可與下述液晶配向劑中的溶劑相同或不同,且用於聚縮合反應中的溶劑並無特別的限制,只要是可溶解反應物與生成物即可。溶劑較佳為包括但不限於(1)非質子系極性溶劑,例如:N-甲基-2-吡咯烷酮(N-methyl-2- pyrrolidinone;NMP)、N,N-二甲基乙醯胺、N,N-二甲基甲醯胺、二甲基亞碸、γ-丁內酯、四甲基尿素或六甲基磷酸三胺等的非質子系極性溶劑;或(2)酚系溶劑,例如:間-甲酚、二甲苯酚、酚或鹵化酚類等的酚系溶劑。基於混合物的總使用量為100重量份,用於聚縮合反應中的溶劑的使用量較佳為200重量份至2000重量份,且更佳為300重量份至1800重量份。The solvent used in the polycondensation reaction may be the same as or different from the solvent in the liquid crystal alignment agent described below, and the solvent used in the polycondensation reaction is not particularly limited as long as it can dissolve the reactant and the product. The solvent preferably includes, but is not limited to (1) an aprotic polar solvent, such as: N-methyl-2-pyrrolidinone (NMP), N, N-dimethylacetamide, Aprotic polar solvents such as N, N-dimethylformamide, dimethylmethylene sulfoxide, γ-butyrolactone, tetramethylurea or hexamethyl phosphate triamine; or (2) phenolic solvents, For example: m-cresol, xylenol, phenol or halogenated phenols. The use amount of the solvent used in the polycondensation reaction is preferably 200 parts by weight to 2000 parts by weight, and more preferably 300 parts by weight to 1800 parts by weight based on the total use amount of the mixture.

值得注意的是,於聚縮合反應中,溶劑可併用適量的貧溶劑,其中貧溶劑不會造成聚醯胺酸析出。貧溶劑可以使用單獨一種或者組合多種來使用,且其包括但不限於(1)醇類,例如:甲醇、乙醇、異丙醇、環己醇、乙二醇、丙二醇、1,4-丁二醇或三乙二醇等的醇類;(2)酮類,例如:丙酮、甲基乙基酮、甲基異丁基酮、環己酮等的酮類;(3)酯類,例如:醋酸甲酯、醋酸乙酯、醋酸丁酯、草酸二乙酯、丙二酸二乙酯或乙二醇乙基醚醋酸酯等的酯類;(4)醚類,例如:二乙基醚、乙二醇甲基醚、乙二醇乙基醚、乙二醇正丙基醚、乙二醇異丙基醚、乙二醇正丁基醚、乙二醇二甲基醚或二乙二醇二甲基醚等的醚類;(5)鹵化烴類,例如:二氯甲烷、1,2-二氯乙烷、1,4-二氯丁烷、三氯乙烷、氯苯或鄰-二氯苯等的鹵化烴類;或(6)烴類,例如:四氫呋喃、己烷、庚烷、辛烷、苯、甲苯或二甲苯等的烴類或上述溶劑的任意組合。基於二胺組份(b)的使用量為100重量份,貧溶劑的用量較佳為0重量份至60重量份,且更佳為0重量份至50重量份。製備聚醯亞胺的方法 It is worth noting that in the polycondensation reaction, an appropriate amount of a lean solvent can be used in combination with the solvent, wherein the lean solvent does not cause the polyamic acid to precipitate. The lean solvent can be used singly or in combination, and it includes but is not limited to (1) alcohols, such as: methanol, ethanol, isopropanol, cyclohexanol, ethylene glycol, propylene glycol, 1,4-butane Alcohols or alcohols such as triethylene glycol; (2) ketones, such as: ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone; (3) esters, such as: Esters such as methyl acetate, ethyl acetate, butyl acetate, diethyl oxalate, diethyl malonate, or ethylene glycol ethyl ether acetate; (4) ethers, such as diethyl ether, Ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether, or diethylene glycol dimethyl ether Ethers such as alkyl ethers; (5) halogenated hydrocarbons, such as: dichloromethane, 1,2-dichloroethane, 1,4-dichlorobutane, trichloroethane, chlorobenzene, or o-dichloro Halogenated hydrocarbons such as benzene; or (6) hydrocarbons, for example: hydrocarbons such as tetrahydrofuran, hexane, heptane, octane, benzene, toluene or xylene, or any combination of the above solvents. Based on the used amount of the diamine component (b) being 100 parts by weight, the amount of the lean solvent is preferably 0 to 60 parts by weight, and more preferably 0 to 50 parts by weight. Method for preparing polyfluorene

製備聚醯亞胺的方法為將上述製備聚醯胺酸的方法所製的聚醯胺酸在脫水劑及觸媒的存在下進行加熱而得。在加熱過程中,聚醯胺酸中的醯胺酸官能基可經由脫水閉環反應轉變成醯亞胺官能基(即醯亞胺化)。The method for preparing polyimide is obtained by heating the polyamidic acid prepared by the method for preparing polyamidic acid in the presence of a dehydrating agent and a catalyst. During the heating process, the arsenic acid functional group in the polyarsenic acid can be converted into the arsonimine functional group (that is, arsonimation) through a dehydration ring-closing reaction.

用於脫水閉環反應中的溶劑可與液晶配向劑中的溶劑(B)相同,故在此不另贅述。基於聚醯胺酸的使用量為100重量份,用於脫水閉環反應中的溶劑的使用量較佳為200重量份至2000重量份,且更佳為300重量份至1800重量份。The solvent used in the dehydration ring-closing reaction may be the same as the solvent (B) in the liquid crystal alignment agent, so it will not be repeated here. The amount of the solvent used in the dehydration ring-closing reaction is preferably 200 to 2000 parts by weight, and more preferably 300 to 1800 parts by weight, based on 100 parts by weight of the polyamic acid used.

為獲得較佳的聚醯胺酸的醯亞胺化程度,脫水閉環反應的操作溫度較佳為40℃至200℃,更佳為40℃至150℃。若脫水閉環反應的操作溫度低於40℃時,醯亞胺化的反應不完全,而降低聚醯胺酸的醯亞胺化程度。然而,若脫水閉環反應的操作溫度高於200℃時,所得的聚醯亞胺的重量平均分子量偏低。In order to obtain a better degree of polyimidation of the polyimide, the operating temperature of the dehydration ring-closing reaction is preferably 40 ° C to 200 ° C, and more preferably 40 ° C to 150 ° C. If the operating temperature of the dehydration ring-closing reaction is lower than 40 ° C, the imidization reaction is not complete, and the degree of imidization of the polyacid is reduced. However, if the operating temperature of the dehydration ring-closing reaction is higher than 200 ° C, the weight average molecular weight of the obtained polyfluorene imine is low.

用於脫水閉環反應中的脫水劑可選自於酸酐類化合物,其具體例如:醋酸酐、丙酸酐或三氟醋酸酐等的酸酐類化合物。基於聚醯胺酸為1莫耳,脫水劑的使用量為0.01莫耳至20莫耳。用於脫水閉環反應中的觸媒可選自於(1)吡啶類化合物,例如:吡啶、三甲基吡啶或二甲基吡啶等的吡啶類化合物;(2)三級胺類化合物,例如:三乙基胺等的三級胺類化合物。基於脫水劑的使用量為1莫耳,觸媒的使用量可為0.5莫耳至10莫耳。製備聚醯亞胺系嵌段共聚合物的方法 The dehydrating agent used in the dehydration ring-closure reaction may be selected from acid anhydride compounds, and specific examples thereof include acid anhydride compounds such as acetic anhydride, propionic anhydride, and trifluoroacetic anhydride. Based on 1 mole of polyamic acid, the amount of dehydrating agent used is 0.01 to 20 moles. The catalyst used in the dehydration ring-closing reaction may be selected from (1) pyridine compounds, such as pyridine, trimethylpyridine, or dimethylpyridine; and (2) tertiary amine compounds, such as: Tertiary amines such as triethylamine. Based on the amount of dehydrating agent used is 1 mole, the amount of catalyst used can be 0.5 to 10 moles. Method for preparing polyfluorene imide block copolymer

聚醯亞胺系嵌段共聚合物為選自聚醯胺酸嵌段共聚合物、聚醯亞胺嵌段共聚合物、聚醯胺酸-聚醯亞胺嵌段共聚合物或上述聚合物的任意組合。The polyimide-based block copolymer is selected from the group consisting of a polyimide block copolymer, a polyimide block copolymer, a polyimide-polyimide block copolymer, or the above-mentioned polymerization. Any combination of things.

製備聚醯亞胺系嵌段共聚合物的方法較佳為先將起始物溶解於溶劑中,並進行聚縮合反應,其中起始物包括至少一種聚醯胺酸及/或至少一種聚醯亞胺,且可進一步包括四羧酸二酐組份(a)與二胺組份(b)。The method for preparing a polyfluorene-based block copolymer is preferably firstly dissolving a starting material in a solvent and performing a polycondensation reaction, wherein the starting material includes at least one polyamidic acid and / or at least one polyfluorene The imine may further include a tetracarboxylic dianhydride component (a) and a diamine component (b).

起始物中的四羧酸二酐組份與二胺組份可與製備聚醯胺酸的方法中所使用的四羧酸二酐組份(a)與二胺組份(b)相同,且用於聚縮合反應中的溶劑可與下述液晶配向劑中的溶劑(B)相同,在此不另贅述。The tetracarboxylic dianhydride component and the diamine component in the starting material may be the same as the tetracarboxylic dianhydride component (a) and the diamine component (b) used in the method for preparing a polyamic acid, In addition, the solvent used in the polycondensation reaction may be the same as the solvent (B) in the liquid crystal alignment agent described below, and details are not described herein again.

基於起始物的使用量為100重量份,用於聚縮合反應中的溶劑的使用量較佳為200重量份至2000重量份,且更佳為300重量份至1800重量份。聚縮合反應的操作溫度較佳為0℃至200℃,且更佳為0℃至100℃。The used amount of the solvent used in the polycondensation reaction is preferably 200 to 2000 parts by weight, and more preferably 300 to 1800 parts by weight based on the used amount of the starting material. The operating temperature of the polycondensation reaction is preferably 0 ° C to 200 ° C, and more preferably 0 ° C to 100 ° C.

起始物較佳為包括但不限於(1)二種末端基相異且結構相異的聚醯胺酸;(2)二種末端基相異且結構相異的聚醯亞胺;(3)末端基相異且結構相異的聚醯胺酸及聚醯亞胺;(4)聚醯胺酸、四羧酸二酐組份與二胺組份,其中,四羧酸二酐組份與二胺組份之中的至少一種與形成聚醯胺酸所使用的四羧酸二酐組份與二胺組份的結構相異;(5)聚醯亞胺、四羧酸二酐組份與二胺組份,其中,四羧酸二酐組份與二胺組份中的至少一種與形成聚醯亞胺所使用的四羧酸二酐組份與二胺組份的結構相異;(6)聚醯胺酸、聚醯亞胺、四羧酸二酐組份與二胺組份,其中,四羧酸二酐組份與二胺組份中的至少一種與形成聚醯胺酸或聚醯亞胺所使用的四羧酸二酐組份與二胺組份的結構相異;(7)二種結構相異的聚醯胺酸、四羧酸二酐組份與二胺組份;(8)二種結構相異的聚醯亞胺、四羧酸二酐組份與二胺組份;(9)二種末端基為酸酐基且結構相異的聚醯胺酸以及二胺組份;(10)二種末端基為胺基且結構相異的聚醯胺酸以及四羧酸二酐組份;(11)二種末端基為酸酐基且結構相異的聚醯亞胺以及二胺組份;或者(12)二種末端基為胺基且結構相異的聚醯亞胺以及四羧酸二酐組份。The starting materials preferably include, but are not limited to, (1) two polyamido acids having different terminal groups and different structures; (2) two polyimines having different terminal groups and different structures; (3) ) Polyamidic acid and polyimide having different terminal groups and different structures; (4) Polyamidic acid, tetracarboxylic dianhydride component and diamine component, of which, tetracarboxylic dianhydride component And at least one of the diamine component is different from the structure of the tetracarboxylic dianhydride component and the diamine component used to form the polyamidic acid; (5) the polyamidoimide and the tetracarboxylic dianhydride group And diamine components, wherein at least one of the tetracarboxylic dianhydride component and the diamine component is different from the structure of the tetracarboxylic dianhydride component and the diamine component used to form the polyimide ; (6) at least one of a polyamine acid, a polyimide, a tetracarboxylic dianhydride component, and a diamine component, wherein at least one of the tetracarboxylic dianhydride component and the diamine component forms a polyamine The structure of the tetracarboxylic dianhydride component used by the acid or polyimide is different from that of the diamine component; (7) Two kinds of polyamidic acid, tetracarboxylic dianhydride component and diamine having different structures Component; (8) two structural phases Polyimide, tetracarboxylic dianhydride component and diamine component; (9) two polyamines and diamine components whose terminal groups are acid anhydride groups and different in structure; (10) two kinds of terminals Polyamines and tetracarboxylic dianhydride components whose groups are amine groups and are different in structure; (11) Polyimide and diamine components whose terminal groups are acid anhydride groups and are different in structure; or (12 ) Two kinds of polyimide and tetracarboxylic dianhydride components whose terminal groups are amine groups and have different structures.

在不影響本發明的功效的範圍內,聚醯胺酸、聚醯亞胺以及聚醯亞胺系嵌段共聚合物較佳為先進行分子量調節後的末端修飾型聚合物。藉由使用末端修飾型的聚合物,可改善液晶配向劑的塗佈性能。製備末端修飾型聚合物的方式可藉由在聚醯胺酸進行聚縮合反應的同時,加入單官能性化合物來製得。As long as the efficacy of the present invention is not affected, the polyamidic acid, polyamidoimide, and polyamidoimide block copolymer are preferably terminally modified polymers after molecular weight adjustment. By using a terminal-modified polymer, the coating performance of the liquid crystal alignment agent can be improved. The method for preparing the terminal-modified polymer can be prepared by adding a polyfunctional compound while the polyamic acid is undergoing a polycondensation reaction.

單官能性化合物的具體例包括但不限於(1)一元酸酐,例如:馬來酸酐、鄰苯二甲酸酐、衣康酸酐、正癸基琥珀酸酐、正十二烷基琥珀酸酐、正十四烷基琥珀酸酐或正十六烷基琥珀酸酐等一元酸酐;(2)單胺化合物,例如:苯胺、環己胺、正丁胺、正戊胺、正己胺、正庚胺、正辛胺、正壬胺、正癸胺、正十一烷胺、正十二烷胺、正十三烷胺、正十四烷胺、正十五烷胺、正十六烷胺、正十七烷胺、正十八烷胺或正二十烷胺等單胺化合物;或(3)單異氰酸酯化合物,例如:異氰酸苯酯或異氰酸萘基酯等單異氰酸酯化合物。Specific examples of monofunctional compounds include, but are not limited to (1) monobasic anhydrides, such as: maleic anhydride, phthalic anhydride, itaconic anhydride, n-decylsuccinic anhydride, n-dodecylsuccinic anhydride, n-tetradecyl Monobasic anhydrides such as alkyl succinic anhydride or n-hexadecyl succinic anhydride; (2) monoamine compounds such as: aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, N-nonylamine, n-decylamine, n-undecylamine, n-dodecylamine, n-tridecylamine, n-tetradecanylamine, n-pentadecylamine, n-hexadecylamine, n-heptadecanylamine, Monoamine compounds such as n-octadecylamine or n-eicosylamine; or (3) monoisocyanate compounds, such as monoisocyanate compounds such as phenyl isocyanate or naphthyl isocyanate.

本發明的聚合物(A)根據凝膠滲透色層分析法(Gel Permeation Chromatography, GPC)所測得經聚苯乙烯換算的重量平均分子量為5,000至50,000,較佳為6,000至48,000,更佳為7,000至45,000。溶劑( B The polymer (A) of the present invention has a polystyrene-equivalent weight average molecular weight as measured by Gel Permeation Chromatography (GPC) of 5,000 to 50,000, preferably 6,000 to 48,000, and more preferably 7,000 to 45,000. Solvent ( B )

本發明的液晶配向劑中所使用的溶劑並無特別的限制,只要是可溶解聚合物(A)與其他任意成份且並不與其產生反應即可,較佳為同前述合成聚醯胺酸中所使用的溶劑,同時,亦可併用合成該聚醯胺酸時所使用的貧溶劑。The solvent used in the liquid crystal alignment agent of the present invention is not particularly limited, as long as it is a soluble polymer (A) and any other component and does not react therewith, it is preferably the same as that in the aforementioned synthetic polyamide. The solvent to be used may be used in combination with the lean solvent used in the synthesis of the polyamic acid.

溶劑(B)的具體例包括但不限於N-甲基-2-吡咯烷酮、γ-丁內酯、γ-丁內醯胺、4-羥基-4-甲基-2-戊酮、乙二醇單甲基醚、乳酸丁酯、乙酸丁酯、甲氧基丙酸甲酯、乙氧基丙酸乙酯、乙二醇甲基醚、乙二醇乙基醚、乙二醇正丙基醚、乙二醇異丙基醚、乙二醇正丁基醚(ethylene glycol n-butyl ether)、乙二醇二甲基醚、乙二醇乙基醚乙酸酯、二乙二醇二甲基醚、二乙二醇二乙基醚、二乙二醇單甲基醚、二乙二醇單乙基醚、二乙二醇單甲基醚乙酸酯、二乙二醇單乙基醚乙酸酯或N,N-二甲基甲醯胺或N,N-二甲基乙醯胺(N,N-dimethyl acetamide)等。溶劑(B)可以單獨使用或者組合多種來使用。Specific examples of the solvent (B) include, but are not limited to, N-methyl-2-pyrrolidone, γ-butyrolactone, γ-butyrolactam, 4-hydroxy-4-methyl-2-pentanone, and ethylene glycol Monomethyl ether, butyl lactate, butyl acetate, methyl methoxypropionate, ethyl ethoxypropionate, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol n-propyl ether, Ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diethylene glycol dimethyl ether, Diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate Or N, N-dimethylformamide or N, N-dimethyl acetamide, etc. The solvent (B) may be used alone or in combination.

基於聚合物(A)的使用量為100重量份,溶劑(B)的使用量為800至4000重量份,較佳為900至3500重量份,且更佳為1000至3000重量份。添加劑( C Based on 100 parts by weight of the polymer (A), 800 to 4000 parts by weight of the solvent (B), preferably 900 to 3500 parts by weight, and more preferably 1000 to 3000 parts by weight. Additive ( C )

在不影響本發明的功效的範圍內,液晶配向劑還可選擇性地添加添加劑(C),其中添加劑(C)包括環氧化合物、具有官能性基團的矽烷化合物,或其組合。添加劑(C)的作用是用來提高該液晶配向膜與基板表面的附著性。To the extent that the efficacy of the present invention is not affected, the liquid crystal alignment agent may optionally add an additive (C), where the additive (C) includes an epoxy compound, a silane compound having a functional group, or a combination thereof. The function of the additive (C) is to improve the adhesion between the liquid crystal alignment film and the substrate surface.

環氧化合物包括但不限於乙二醇二環氧丙基醚、聚乙二醇二環氧丙基醚、丙二醇二環氧丙基醚、三丙二醇二環氧丙基醚、聚丙二醇二環氧丙基醚、新戊二醇二環氧丙基醚、1,6-己二醇二環氧丙基醚、丙三醇二環氧丙基醚、2,2-二溴新戊二醇二環氧丙基醚、1,3,5,6-四環氧丙基-2,4-己二醇、N,N,N’,N’-四環氧丙基-間-二甲苯二胺、1,3-雙(N,N-二環氧丙基胺基甲基)環己烷、N,N,N’,N’-四環氧丙基-4,4’-二胺基二苯基甲烷、3-(N,N-二環氧丙基)胺基丙基三甲氧基矽烷,或上述化合物的組合。Epoxy compounds include, but are not limited to, ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether Propyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromo neopentyl glycol di Glycidyl ether, 1,3,5,6-tetraglycidyl-2,4-hexanediol, N, N, N ', N'-tetraglycidyl-m-xylylenediamine , 1,3-bis (N, N-diepoxypropylaminomethyl) cyclohexane, N, N, N ', N'-tetraepoxypropyl-4,4'-diaminodiamine Phenylmethane, 3- (N, N-diglycidyl) aminopropyltrimethoxysilane, or a combination of the foregoing.

環氧基化合物可單獨使用或組合多種來使用。The epoxy compound may be used alone or in combination.

基於聚合物(A)的使用量為100重量份,環氧化合物的使用量可為0至40重量份,且較佳為0.1重量份至30重量份。The use amount of the epoxy compound may be 0 to 40 parts by weight, and preferably 0.1 to 30 parts by weight based on the use amount of the polymer (A).

具有官能性基團的矽烷化合物的具體例包括但不限於3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷(3-ureidopropyltrimethoxy silane)、3-脲基丙基三乙氧基矽烷、N-乙氧基羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基丙基三乙氧基矽烷、N-三乙氧基矽烷基丙基三伸乙三胺、N-三甲氧基矽烷基丙基三伸乙三胺、10-三甲氧基矽烷基-1,4,7-三吖癸烷、10-三乙氧基矽烷基-1,4,7-三吖癸烷、9-三甲氧基矽烷基-3,6-二吖壬基醋酸酯、9-三乙氧基矽烷基-3,6-二吖壬基醋酸酯、N-芐基-3-胺基丙基三甲氧基矽烷、N-芐基-3-胺基丙基三乙氧基矽烷、N-苯基-3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基丙基三乙氧基矽烷、N-雙(氧化乙烯)-3-胺基丙基三甲氧基矽烷、N-雙(氧化乙烯)-3-胺基丙基三乙氧基矽烷,或上述化合物的組合。Specific examples of the silane compound having a functional group include, but are not limited to, 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 2-aminopropyltrimethoxysilane, 2 -Aminopropyltriethoxysilane, N- (2-aminoethyl) -3-aminopropyltrimethoxysilane, N- (2-aminoethyl) -3-aminopropyl Methyldimethoxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltrimethoxysilane, N-ethoxycarbonyl-3-aminopropyl Trimethoxysilane, N-ethoxycarbonyl-3-aminopropyltriethoxysilane, N-triethoxysilylpropyltriethylenetriamine, N-trimethoxysilylpropyltriamine Ethylenetriamine, 10-trimethoxysilyl-1,4,7-triazine, 10-triethoxysilyl-1,4,7-triazine, 9-trimethoxysilane -3,6-diazinyl acetate, 9-triethoxysilyl-3,6-diazinyl acetate, N-benzyl-3-aminopropyltrimethoxysilane, N -Benzyl-3-aminopropyltriethoxysilane, N-phenyl-3-aminopropyltrimethoxysilane, N-phenyl-3-aminopropyltriethoxy Silane, N- bis (oxyethylene) -3-aminopropyl trimethoxy Silane, N- bis (oxyethylene) -3-aminopropyl triethoxysilane Silane, or combinations of the above compounds.

具有官能性基團的矽烷化合物可以單獨使用或組合多種來使用。The silane compound having a functional group may be used alone or in combination.

基於聚合物(A)的使用量為100重量份,具有官能性基團的矽烷化合物的使用量可為0至10重量份,且較佳為0.5重量份至10重量份。The use amount of the silane compound having a functional group may be 0 to 10 parts by weight, and preferably 0.5 to 10 parts by weight based on the use amount of the polymer (A).

基於聚合物(A)的總使用量為100重量份,添加劑(C)的使用量較佳為0.5至50重量份,且更佳為1至40重量份。 液晶配向劑的製造方法 The use amount of the additive (C) is preferably 0.5 to 50 parts by weight, and more preferably 1 to 40 parts by weight based on the total use amount of the polymer (A). < Manufacturing method of liquid crystal alignment agent >

液晶配向劑的製造方法並無特別的限制,可採用一般的混合方法來製備。舉例而言,先將四羧酸二酐組份(a)及二胺組份(b)混合均勻,以反應形成一聚合物(A)。接著,將聚合物(A)於溫度為0℃至200℃的條件下加入溶劑(B),並可選擇性地添加添加劑(C),以攪拌裝置持續攪拌至溶解即可。較佳地,於20℃至60℃的溫度下,將溶劑(B)添加至聚合物中。 液晶配向膜的製造方法 The manufacturing method of the liquid crystal alignment agent is not particularly limited, and it can be prepared by a general mixing method. For example, the tetracarboxylic dianhydride component (a) and the diamine component (b) are first mixed uniformly to form a polymer (A). Next, the polymer (A) is added to the solvent (B) at a temperature of 0 ° C. to 200 ° C., and the additive (C) can be optionally added, and the stirring device can be continuously stirred until dissolved. Preferably, the solvent (B) is added to the polymer at a temperature of 20 ° C to 60 ° C. < Manufacturing method of liquid crystal alignment film >

本發明的液晶配向膜可由上述的液晶配向劑所形成。The liquid crystal alignment film of the present invention can be formed of the liquid crystal alignment agent described above.

具體而言,液晶配向膜的製備方式例如可以是:將液晶配向劑利用輥塗佈法、旋轉塗佈法、印刷法或噴墨法(ink-jet)等方法,塗佈在基板的表面上,形成預塗層。接著,對預塗層進行預烤處理(pre-bake treatment)、後烤處理(post-bake treatment)及配向處理(alignment treatment)後而製得形成了液晶配向膜的基板。Specifically, the preparation method of the liquid crystal alignment film may be, for example, applying a liquid crystal alignment agent on a surface of a substrate by a method such as a roll coating method, a spin coating method, a printing method, or an ink-jet method. To form a pre-coating. Then, a pre-bake treatment, a post-bake treatment, and an alignment treatment are performed on the pre-coat layer to obtain a substrate on which a liquid crystal alignment film is formed.

預烤處理的目的在於使預塗層中的有機溶劑揮發。預烤處理的操作溫度較佳為30℃至120℃,且更佳為40℃至110℃,尤佳為50℃至100℃。The purpose of the pre-baking treatment is to volatilize the organic solvent in the pre-coating. The operating temperature of the pre-baking treatment is preferably 30 ° C to 120 ° C, more preferably 40 ° C to 110 ° C, and even more preferably 50 ° C to 100 ° C.

配向處理並無特別的限制,可將尼龍、人造絲或棉類等纖維所做成的布料纏繞在滾筒上,並以一定方向摩擦進行配向。There is no particular limitation on the alignment treatment. Cloths made of fibers such as nylon, rayon, or cotton can be wound on a drum and aligned by rubbing in a certain direction.

後烤處理步驟的目的在於使預塗層中的聚合物再進一步進行脫水閉環(醯亞胺化)反應。後烤處理的操作溫度較佳為150℃至300℃,更佳為180℃至280℃,尤佳為200℃至250℃。 液晶顯示元件及其製造方法 The purpose of the post-baking treatment step is to make the polymer in the pre-coating layer undergo a further dehydration ring closure (fluorine imidization) reaction. The operating temperature of the post-baking treatment is preferably 150 ° C to 300 ° C, more preferably 180 ° C to 280 ° C, and even more preferably 200 ° C to 250 ° C. <Liquid crystal display device and manufacturing method>

本發明的液晶顯示元件包括由本發明的液晶配向劑所形成的液晶配向膜。液晶顯示元件的製作方式為本技術領域者所周知。因此,以下僅簡單地進行陳述。The liquid crystal display element of the present invention includes a liquid crystal alignment film formed of the liquid crystal alignment agent of the present invention. The manufacturing method of the liquid crystal display element is well known to those skilled in the art. Therefore, the following is simply stated.

圖1是根據本發明一實施例的液晶顯示元件的側視圖。液晶顯示元件100包括一第一單元110、一第二單元120及一液晶單元130,其中第二單元120與第一單元110間隔相對,且液晶單元130設置在第一單元110與第二單元120之間。FIG. 1 is a side view of a liquid crystal display element according to an embodiment of the present invention. The liquid crystal display element 100 includes a first unit 110, a second unit 120, and a liquid crystal unit 130. The second unit 120 is spaced apart from the first unit 110, and the liquid crystal unit 130 is disposed between the first unit 110 and the second unit 120. between.

第一單元110包括一第一基板112、一電極114及一第一液晶配向膜116,其中電極114以櫛齒型圖案化的方式形成於第一基板112之表面,且第一液晶配向膜116形成在電極114之表面。The first unit 110 includes a first substrate 112, an electrode 114, and a first liquid crystal alignment film 116. The electrodes 114 are formed on the surface of the first substrate 112 in a dentate pattern, and the first liquid crystal alignment film 116 It is formed on the surface of the electrode 114.

第二單元120包括一第二基板122及一第二液晶配向膜126,其中第二液晶配向膜126形成在第二基板122的表面。The second unit 120 includes a second substrate 122 and a second liquid crystal alignment film 126. The second liquid crystal alignment film 126 is formed on a surface of the second substrate 122.

第一基板112與第二基板122是選自於透明材料等,其中,透明材料包含但不限於用於液晶顯示裝置的無鹼玻璃、鈉鈣玻璃、硬質玻璃(派勒斯玻璃)、石英玻璃、聚乙烯對苯二甲酸酯、聚丁烯對苯二甲酸酯、聚醚碸、聚碳酸酯等。電極114的材質是擇自於氧化錫(SnO2 )、氧化銦-氧化錫(In2 O3 -SnO2 )等的透明電極;或鉻等金屬電極。The first substrate 112 and the second substrate 122 are selected from transparent materials. The transparent materials include, but are not limited to, alkali-free glass, soda-lime glass, hard glass (Pales glass), and quartz glass used in liquid crystal display devices. , Polyethylene terephthalate, polybutylene terephthalate, polyether fluorene, polycarbonate, etc. The material of the electrode 114 is a transparent electrode selected from tin oxide (SnO 2 ), indium oxide-tin oxide (In 2 O 3 -SnO 2 ), or a metal electrode such as chromium.

第一液晶配向膜116及第二液晶配向膜126分別為上述之液晶配向膜,其作用在於使液晶單元130形成一預傾角,且液晶單元130可被電極114產生的平行電場驅動。The first liquid crystal alignment film 116 and the second liquid crystal alignment film 126 are the above-mentioned liquid crystal alignment films, respectively, and their function is to make the liquid crystal cell 130 form a pretilt angle, and the liquid crystal cell 130 can be driven by the parallel electric field generated by the electrode 114.

液晶單元130所使用的液晶可單獨或混合複數種使用,該液晶包含但不限於二胺基苯類液晶、噠嗪(pyridazine)類液晶、希夫氏鹼(shiff base)類液晶、氧化偶氮基(azoxy)類液晶、聯苯類液晶、苯基環己烷類液晶、聯苯(biphenyl)類液晶、苯基環己烷(phenylcyclohexane)類液晶、酯(ester)類液晶、三聯苯(terphenyl)、聯苯環己烷(biphenylcyclohexane)類液晶、嘧啶(pyrimidine)類液晶、二氧六環(dioxane)類液晶、雙環辛烷(bicyclooctane)類液晶、立方烷(cubane)類液晶等,且可視需求再添加如氯化膽固醇(cholesteryl chloride)、膽固醇壬酸酯(cholesteryl nonanoate)、膽固醇碳酸酯(cholesteryl carbonate)等的膽固醇型液晶,或是以商品名為「C-15」、「CB-15」(默克公司製造)的對掌(chiral)劑等,或者對癸氧基苯亞甲基-對胺基-2-甲基丁基肉桂酸酯等強誘電性(ferroelectric)類液晶。The liquid crystal used in the liquid crystal cell 130 may be used alone or in combination. The liquid crystal includes, but is not limited to, a diaminobenzene-based liquid crystal, a pyridazine-based liquid crystal, a shiff base-based liquid crystal, and an azo oxide. Azoxy liquid crystal, biphenyl liquid crystal, phenylcyclohexane liquid crystal, biphenyl liquid crystal, phenylcyclohexane liquid crystal, ester liquid crystal, terphenyl ), Biphenylcyclohexane-based liquid crystal, pyrimidine-based liquid crystal, dioxane-based liquid crystal, bicyclooctane-based liquid crystal, cubane-based liquid crystal, etc., and visible Need to add cholesterol type liquid crystals such as cholesterol (cholesteryl chloride), cholesterol nonanoate (cholesteryl nonanoate), cholesterol carbonate (cholesteryl carbonate), etc., or under the trade names "C-15", "CB-15 "Chiral" (manufactured by Merck), or ferroelectric liquid crystals such as p-decyloxymethylene-p-amino-2-methylbutyl cinnamate.

本發明的液晶配向劑所製作之液晶顯示元件適用於各式向列液晶,如TN、STN、TFT、VA、IPS等之液晶顯示元件。此外,根據所選擇的液晶,亦可使用於強誘電性或反強誘電性等不同的液晶顯示元件。上述液晶顯示元件中,特別適用於IPS型之液晶顯示元件。The liquid crystal display element produced by the liquid crystal alignment agent of the present invention is suitable for various types of nematic liquid crystals, such as TN, STN, TFT, VA, IPS and other liquid crystal display elements. In addition, depending on the selected liquid crystal, it can also be used for liquid crystal display elements having different strong electromotive force or anti-strong electromotive force. Among the above-mentioned liquid crystal display elements, it is particularly suitable for an IPS-type liquid crystal display element.

以下將列舉實施例詳細說明本發明,但本發明並不侷限於這些實施例所揭露的內容。 實施例 四羧酸二酐化合物( a1 )的合成例 Hereinafter, the present invention will be described in detail with examples, but the present invention is not limited to the contents disclosed in these examples. < Example > Synthesis example of tetracarboxylic dianhydride compound ( a1 )

以下說明四羧酸二酐化合物(a1)的合成例a1-1至合成例a1-8:合成例 a1-1 The synthesis example a1-1 to a1-8 of the tetracarboxylic dianhydride compound (a1) will be described below: Synthesis example a1-1

在容積100毫升的四頸燒瓶上設置氬氣入口、攪拌器、冷凝管及溫度計,並導入氬氣。然後,在四頸燒瓶中,將0.36克(0.0042莫耳)的哌嗪、36毫克(0.16毫莫耳)的醋酸鈀、56毫克(0.31毫莫耳)的對甲苯亞磺酸鈉、2.32克(0.021莫耳)的第三戊醇鈉加入14毫升的甲苯中。之後加入0.11克(0.31毫莫耳)的二金剛烷基丁基膦,並於室溫下攪拌30分鐘。接著,在冰浴環境下加入溶於6毫升的甲苯的1.06克(0.0053莫耳)的4-氯基鄰苯二甲酸,並於冰浴下攪拌反應45分鐘。接著,在冰浴環境下加入濃度為2 M的鹽酸16毫升,以生成析出物(a1-1’)。最後,將生成的1.08克析出物(a1-1’)與21克的醋酸酐在50毫升的反應瓶中,以溫度70℃,反應時間3小時的條件下進行脫水環化反應。待反應結束後,過濾所得的產物,即可得如式(a-1-1)所示的四羧酸二酐化合物。合成例 a1 -2 A four-necked flask with a volume of 100 ml was provided with an argon inlet, a stirrer, a condenser, and a thermometer, and argon was introduced. Then, in a four-necked flask, 0.36 g (0.0042 mol) of piperazine, 36 mg (0.16 mmol) of palladium acetate, 56 mg (0.31 mmol) of sodium p-toluenesulfinate, 2.32 g (0.021 mole) of sodium tripentoxide was added to 14 ml of toluene. Then, 0.11 g (0.31 mmol) of diamantylbutylphosphine was added and stirred at room temperature for 30 minutes. Next, 1.06 g (0.0053 mole) of 4-chlorophthalic acid dissolved in 6 ml of toluene was added in an ice bath environment, and the reaction was stirred in the ice bath for 45 minutes. Next, 16 ml of 2 M hydrochloric acid was added in an ice-bath environment to generate a precipitate (a1-1 '). Finally, 1.08 g of the precipitate (a1-1 ′) and 21 g of acetic anhydride were subjected to a dehydration cyclization reaction at a temperature of 70 ° C. and a reaction time of 3 hours in a 50 ml reaction bottle. After the reaction is completed, the obtained product is filtered to obtain a tetracarboxylic dianhydride compound represented by formula (a-1-1). Synthesis example a1 -2

合成例a1-2是以與合成例a1-1相同的步驟來分別製備,並且其不同處在於:將1.06克(0.0053莫耳)的4-氯基鄰苯二甲酸替換為1.54克(0.0053莫耳)的3-碘基鄰苯二甲酸,以獲得如式(a-1-15)所示的四羧酸二酐化合物。合成例 a1 -3 Synthesis Example a1-2 was prepared separately by the same procedure as Synthesis Example a1-1, and the difference was that 1.06 g (0.0053 mole) of 4-chlorophthalic acid was replaced with 1.54 g (0.0053 mole) Ear) of 3-iodophthalic acid to obtain a tetracarboxylic dianhydride compound represented by formula (a-1-15). Synthesis example a1 -3

合成例a1-3是以與合成例a1-1相同的步驟來分別製備,並且其不同處在於:將1.06克(0.0053莫耳)的4-氯基鄰苯二甲酸替換為1.58克(0.0053莫耳)的5-溴-3-丁基鄰苯二甲酸,以獲得如式(a-1-3)所示的四羧酸二酐化合物。合成例 a1 -4 Synthesis Example a1-3 was prepared separately by the same steps as Synthesis Example a1-1, and the difference was that 1.06 g (0.0053 mole) of 4-chlorophthalic acid was replaced with 1.58 g (0.0053 mole) Ear) of 5-bromo-3-butylphthalic acid to obtain a tetracarboxylic dianhydride compound represented by the formula (a-1-3). Synthesis example a1 -4

合成例a1-4是以與合成例a1-1相同的步驟來分別製備,並且其不同處在於:將1.06克(0.0053莫耳)的4-氯基鄰苯二甲酸替換為1.86克(0.0053莫耳)的5-(苯磺醯基)-3-甲氧基鄰苯二甲酸,以獲得如式(a-1-6)所示的四羧酸二酐化合物。合成例 a1 -5 Synthesis Example a1-4 was prepared separately by the same procedure as Synthesis Example a1-1, and the difference was that 1.06 g (0.0053 mole) of 4-chlorophthalic acid was replaced with 1.86 g (0.0053 mole) Ear) of 5- (benzenesulfonyl) -3-methoxyphthalic acid to obtain a tetracarboxylic dianhydride compound represented by formula (a-1-6). Synthesis example a1 -5

合成例a1-5是以與合成例a1-1相同的步驟來分別製備,並且其不同處在於:將1.06克(0.0053莫耳)的4-氯基鄰苯二甲酸替換為1.24克(0.0053莫耳)的4,5-二氯基鄰苯二甲酸,以獲得如式(a-1-8)所示的四羧酸二酐化合物。合成例 a1 -6 Synthesis Example a1-5 was prepared separately by the same procedure as Synthesis Example a1-1, and the difference was that 1.06 g (0.0053 mole) of 4-chlorophthalic acid was replaced with 1.24 g (0.0053 mole) Ear) of 4,5-dichloro phthalic acid to obtain a tetracarboxylic dianhydride compound represented by the formula (a-1-8). Synthesis example a1 -6

在容積100毫升的四頸燒瓶上設置氬氣入口、攪拌器、冷凝管及溫度計,並導入氬氣。然後,在四頸燒瓶中,將0.41克(0.0041莫耳)的2-甲基哌嗪、36毫克(0.16毫莫耳)的醋酸鈀、56毫克(0.31毫莫耳)的對甲苯亞磺酸鈉、2.32克(0.021莫耳)的第三戊醇鈉加入14毫升的甲苯中。之後加入0.11克(0.31毫莫耳)的二金剛烷基丁基膦,並於室溫下攪拌30分鐘。接著,在冰浴環境下加入溶於6毫升的甲苯的1.35克(0.0052莫耳)的3,4-二氟鄰苯二甲酸二乙酯,並於冰浴下攪拌反應45分鐘。接著,在冰浴環境下加入濃度為2 M的鹽酸16毫升,以生成析出物(a1-6’)。接著,將生成的1.50克析出物(a1-6’)與20毫升的水、2.4克的氫氧化鉀以及24毫升的乙醇在100毫升的三頸瓶中,以溫度80℃,反應時間3小時的條件下進行水解反應,之後加入濃度為2.5 M的硫酸,使反應溶液呈酸性,以生成析出物(a1-6’’)。最後,將生成的1.21克析出物(a1-6’’)與21克的醋酸酐在50毫升的反應瓶中,以溫度70℃,反應時間3小時的條件下進行脫水環化反應。待反應結束後,過濾所得的產物,即可得如式(a-1-12)所示的四羧酸二酐化合物。合成例 a1 -7 A four-necked flask with a volume of 100 ml was provided with an argon inlet, a stirrer, a condenser, and a thermometer, and argon was introduced. Then, in a four-necked flask, 0.41 g (0.0041 mol) of 2-methylpiperazine, 36 mg (0.16 mmol) of palladium acetate, 56 mg (0.31 mmol) of p-toluenesulfinic acid Sodium, 2.32 g (0.021 mol) of sodium tertiary alcohol were added to 14 ml of toluene. Then, 0.11 g (0.31 mmol) of diamantylbutylphosphine was added and stirred at room temperature for 30 minutes. Next, 1.35 g (0.0052 mol) of 3,4-difluorodiethyl phthalate dissolved in 6 ml of toluene was added in an ice bath environment, and the reaction was stirred in the ice bath for 45 minutes. Next, 16 ml of 2 M hydrochloric acid was added in an ice-bath environment to generate a precipitate (a1-6 '). Next, 1.50 g of the precipitate (a1-6 ') and 20 ml of water, 2.4 g of potassium hydroxide, and 24 ml of ethanol were placed in a 100 ml three-necked flask at a temperature of 80 ° C for a reaction time of 3 hours The hydrolysis reaction was performed under the conditions of 2.5 ° C, and then sulfuric acid with a concentration of 2.5 M was added to make the reaction solution acidic to generate a precipitate (a1-6 ''). Finally, 1.21 g of the precipitate (a1-6 '') and 21 g of acetic anhydride were subjected to a dehydration cyclization reaction at a temperature of 70 ° C. and a reaction time of 3 hours in a 50 ml reaction bottle. After the reaction is completed, the obtained product is filtered to obtain a tetracarboxylic dianhydride compound represented by formula (a-1-12). Synthesis example a1 -7

合成例a1-7是以與合成例a1-6相同的步驟來分別製備,並且其不同處在於:將0.36克(0.0042莫耳)的哌嗪替換為0.48克(0.0042莫耳)的2,3-二甲基哌嗪,以獲得如式(a-1-2)所示的四羧酸二酐化合物。合成例 a1-8 Synthesis Example a1-7 was prepared separately by the same procedure as Synthesis Example a1-6, except that 0.36 g (0.0042 mol) of piperazine was replaced with 0.48 g (0.0042 mol) of 2,3 -Dimethylpiperazine to obtain a tetracarboxylic dianhydride compound represented by formula (a-1-2). Synthesis example a1-8

合成例a1-8是以與合成例a1-6相同的步驟來分別製備,並且其不同處在於:將0.41克(0.0041莫耳)的2-甲基哌嗪替換為0.59克(0.0043莫耳)的2,3,5,6-四甲基哌嗪,將1.35克(0.0052莫耳)的3,4-二氟鄰苯二甲酸二乙酯替換為1.34克的3-氯鄰苯二甲酸二乙酯二甲醇,以獲得如式(a-1-17)所示的四羧酸二酐化合物。聚合物( A 的合成例 Synthesis Example a1-8 was prepared separately by the same procedure as Synthesis Example a1-6, and the difference was that 0.41 g (0.0041 mole) of 2-methylpiperazine was replaced with 0.59 g (0.0043 mole) 2,3,5,6-tetramethylpiperazine, replacing 1.35 g (0.0052 moles) of diethyl 3,4-difluorophthalate with 1.34 g of dichlorophthalate Ethyl dimethanol to obtain a tetracarboxylic dianhydride compound represented by formula (a-1-17). Synthesis example of polymer ( A )

以下說明聚合物(A)的合成例A-1-1至合成例A-1-7、合成例A-2-1至合成例A-2-7以及比較合成例A’-1-1、A’-2-1、A’-2-2:合成例 A-1-1 Synthesis Example A-1-1 to Synthesis Example A-1-7, Synthesis Example A-2-1 to Synthesis Example A-2-7, and Comparative Synthesis Example A'-1-1, Polymer (A) will be described below. A'-2-1, A'-2-2: Synthesis example A-1-1

在容積500毫升的四頸燒瓶上設置氮氣入口、攪拌器、冷凝管及溫度計,並導入氮氣。然後,在四頸燒瓶中,加入1.15克(0.005莫耳)的二(4-胺基苯氧基)甲烷(簡稱為b2-1)、2.16克(0.02莫耳)的對-二胺苯(簡稱為b3-1)、4.96克(0.025莫耳)的4,4’-二胺基二苯基甲烷(簡稱為b3-2)以及80克的N-甲基-2-吡咯烷酮(N-methyl-2-pyrrolidone,簡稱為NMP),並於室溫下攪拌至溶解。接著,加入0.38克(0.001莫耳)的由式(a-1-1)表示的四羧酸二酐化合物(簡稱為a1-1)、9.6克(0.049莫耳)的1,2,3,4-環丁烷四羧酸二酐(簡稱為a2-1)以及20克的NMP,並於室溫下反應2小時。待反應結束後,將反應溶液倒入1500毫升水中,以使聚合物析出。然後,過濾所得的聚合物,並重複以甲醇清洗及過濾三次,置入真空烘箱中,以溫度60℃進行乾燥後,即可得聚合物(A-1-1)。合成例 A-1-2 A-1-7 以及比較合成例 A -1-1 A 500 ml four-necked flask was provided with a nitrogen inlet, a stirrer, a condenser, and a thermometer, and nitrogen was introduced. Then, in a four-necked flask, 1.15 g (0.005 mole) of bis (4-aminophenoxy) methane (abbreviated as b2-1) and 2.16 g (0.02 mole) of p-diaminebenzene ( Referred to as b3-1), 4.96 g (0.025 mol) of 4,4'-diaminodiphenylmethane (referred to as b3-2) and 80 g of N-methyl-2-pyrrolidone (N-methyl -2-pyrrolidone (NMP), and stir at room temperature until dissolved. Next, 0.38 g (0.001 mole) of the tetracarboxylic dianhydride compound (abbreviated as a1-1) represented by the formula (a-1-1) and 9.6 g (0.049 mole) of 1, 2, 3, 4-cyclobutanetetracarboxylic dianhydride (abbreviated as a2-1) and 20 g of NMP, and reacted at room temperature for 2 hours. After the reaction is completed, the reaction solution is poured into 1500 ml of water to precipitate a polymer. Then, the obtained polymer was filtered, repeatedly washed with methanol and filtered three times, put into a vacuum oven, and dried at a temperature of 60 ° C. to obtain a polymer (A-1-1). Synthesis Example A-1-2 to A-1-7 and Comparative Synthesis Example A '-1-1

合成例A-1-2至合成例A-1-7以及比較合成例A’-1-1是以與合成例A-1-1相同的步驟來分別製備聚合物(A-1-2)至(A-1-7)以及(A’-1-1),並且其不同處在於:改變單體的種類及其使用量(如表1所示)。合成例 A-2-1 Synthesis Example A-1-2 to Synthesis Example A-1-7 and Comparative Synthesis Example A'-1-1 In the same procedure as Synthesis Example A-1-1, polymers (A-1-2) were prepared separately. To (A-1-7) and (A'-1-1), and the difference is that the type of monomer and its amount of use are changed (as shown in Table 1). Synthesis Example A-2-1

在容積500毫升的四頸燒瓶上設置氮氣入口、攪拌器、冷凝管及溫度計,並導入氮氣。然後,在四頸燒瓶中,加入1.15克(0.005莫耳)的二(4-胺基苯氧基)甲烷(簡稱為b2-1)、3.97克(0.020莫耳)的4,4’-二胺基二苯基甲烷(簡稱為b3-2)、10.86克(0.025莫耳)的由式(b-3-28)表示的二胺化合物(簡稱為b3-3)以及80克的N-甲基-2-吡咯烷酮(簡稱為NMP),並於室溫下攪拌至溶解。接著,加入0.38克(0.001莫耳)的由式(a-1-1)表示的四羧酸二酐化合物(簡稱為a1-1)、14.7克(0.049莫耳)的3,4-二羧基-1,2,3,4-四氫萘-1-琥珀酸二酐(簡稱為a2-3)以及20克的NMP。於室溫下反應6小時後,加入97克的NMP、2.55克的醋酸酐及19.75克的吡啶,升溫至60℃,且持續攪拌2小時,以進行醯亞胺化反應。待反應結束後,將反應溶液倒入1500毫升水中,以使聚合物析出。然後,過濾所得的聚合物,並重複以甲醇清洗及過濾三次,置入真空烘箱中,以溫度60℃進行乾燥後,即可得聚合物(A-2-1)。合成例 A-2-2 A-2-7 以及比較合成例 A -2-1 A -2-2 A 500 ml four-necked flask was provided with a nitrogen inlet, a stirrer, a condenser, and a thermometer, and nitrogen was introduced. Then, in a four-necked flask, 1.15 g (0.005 mol) of bis (4-aminophenoxy) methane (abbreviated as b2-1) and 3.97 g (0.020 mol) of 4,4'-di Amino diphenylmethane (abbreviated as b3-2), 10.86 g (0.025 mole) of a diamine compound (abbreviated as b3-3) represented by formula (b-3-28), and 80 g of N-formyl 2-Pyrrolidone (abbreviated as NMP), and stirred at room temperature until dissolved. Next, 0.38 g (0.001 mole) of a tetracarboxylic dianhydride compound (abbreviated as a1-1) represented by formula (a-1-1) and 14.7 g (0.049 mole) of 3,4-dicarboxyl were added. -1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride (abbreviated as a2-3) and 20 grams of NMP. After reacting at room temperature for 6 hours, 97 g of NMP, 2.55 g of acetic anhydride, and 19.75 g of pyridine were added, the temperature was raised to 60 ° C., and stirring was continued for 2 hours to carry out the imidization reaction. After the reaction is completed, the reaction solution is poured into 1500 ml of water to precipitate a polymer. Then, the obtained polymer was filtered, and repeatedly washed with methanol and filtered three times, put into a vacuum oven, and dried at a temperature of 60 ° C. to obtain a polymer (A-2-1). Synthesis Example A-2-2 to A-2-7 and Comparative Synthesis Example A '-2-1, A' -2-2

合成例A-2-2至A-2-7以及比較合成例A’-2-1、A’-2-2是以與合成例A-2-1相同的步驟來分別製備聚合物(A-2-2)至(A-2-7)以及(A’-2-1)、(A’-2-2),並且其不同處在於:改變單體的種類及其使用量(如表2所示)。Synthesis Examples A-2-2 to A-2-7 and Comparative Synthesis Examples A'-2-1 and A'-2-2 were prepared in the same manner as in Synthesis Example A-2-1, respectively, and polymers (A -2-2) to (A-2-7) and (A'-2-1), (A'-2-2), and the difference is that: the type of monomer and its amount of use (as shown in the table 2).

表1、表2中標號所對應的化合物如下所示。 The compounds corresponding to the numbers in Tables 1 and 2 are shown below.

[表1] [Table 1]

[表2] 液晶配向劑、液晶配向膜以及液晶顯示元件的實施例與比較例 [Table 2] Examples and comparative examples of liquid crystal alignment agents, liquid crystal alignment films, and liquid crystal display elements

以下說明液晶配向劑、液晶配向膜以及液晶顯示元件的實施例1至實施例14以及比較例1至比較例3:實施例 1 a. 液晶配向劑 Examples 1 to 14 and Comparative Examples 1 to 3 of the liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element are described below: Example 1 a. Liquid crystal alignment agent

秤取100重量份的聚合物(A-1-1)以及800重量份的N-甲基-2-吡咯烷酮(簡稱為B-1),並且在室溫下攪拌混合而形成實施例1的液晶配向劑。b. 液晶配向膜及液晶顯示元件 100 parts by weight of the polymer (A-1-1) and 800 parts by weight of N-methyl-2-pyrrolidone (abbreviated as B-1) were weighed and stirred at room temperature to form the liquid crystal of Example 1. Alignment agent. b. Liquid crystal alignment film and liquid crystal display element

將上述液晶配向劑以印刷機(由日本寫真印刷株式會社製造,型號為S15-036)分別塗佈於兩片具有由ITO(indium-tin-oxide)構成的導電膜的玻璃基板,以形成預塗層。之後,將玻璃基板放置於加熱板上,並以溫度為100℃、時間為5分鐘的條件進行預烘烤。接著,在循環烘箱中,以溫度為220℃、時間為30分鐘的條件進行後烘烤。最後,經過配向處理後,即可獲得上面形成了實施例1的液晶配向膜的玻璃基板。The above-mentioned liquid crystal alignment agent was respectively applied to two glass substrates having a conductive film made of ITO (indium-tin-oxide) by a printer (manufactured by Japan Photo Printing Co., Ltd., model S15-036) to form a pre-form. coating. Thereafter, the glass substrate was placed on a hot plate, and pre-baked under conditions of a temperature of 100 ° C. and a time of 5 minutes. Next, post-baking was performed in a circulating oven under the conditions of a temperature of 220 ° C and a time of 30 minutes. Finally, after the alignment process, the glass substrate on which the liquid crystal alignment film of Example 1 is formed can be obtained.

將上述所獲得的兩片上面形成了液晶配向膜的玻璃基板,其中一片塗以熱壓膠,另一片灑上4μm的隔離壁(spacer)。接著,將兩片玻璃基板進行貼合,再以熱壓機施以10kg的壓力,在溫度為150℃的條件下進行熱壓貼合。然後,以液晶注入機(島津製作所製造,型號為ALIS-100X-CH)進行液晶注入。接著,利用紫外光硬化膠封住液晶注入口,以紫外光燈照光使紫外光硬化膠硬化,並在烘箱中以溫度為60℃、時間為30分鐘的條件進行液晶回火處理(annealing treatment),即可獲得實施例1的液晶顯示元件。One of the two glass substrates with the liquid crystal alignment film formed thereon was coated with hot-press adhesive, and the other one was coated with a 4 μm spacer. Next, the two glass substrates were bonded together, and then a pressure of 10 kg was applied with a hot press, and the bonding was performed by hot pressing at a temperature of 150 ° C. Then, liquid crystal injection was performed using a liquid crystal injection machine (made by Shimadzu Corporation, model number: ALIS-100X-CH). Next, the liquid crystal injection port is sealed with an ultraviolet curing adhesive, and the ultraviolet curing adhesive is hardened with the ultraviolet light, and the liquid crystal is subjected to an annealing treatment in an oven at a temperature of 60 ° C and a time of 30 minutes. That is, the liquid crystal display element of Example 1 can be obtained.

將實施例1的液晶顯示元件以後述各評價方式進行評價,其結果如表3所示。實施例 2 至實施例 14 The liquid crystal display element of Example 1 was evaluated by each evaluation method described later, and the results are shown in Table 3. Examples 2 to 14

實施例2至實施例14的液晶配向劑、液晶配向膜及液晶顯示元件是以與實施例1相同的步驟分別製備,並且其不同處在於:改變成分的種類及其使用量,如表3、表4所示。將實施例2至實施例14所製得液晶顯示元件以後述評價方式進行評價,其結果如表3、表4所示。比較例 1 至比較例 3 The liquid crystal alignment agent, the liquid crystal alignment film, and the liquid crystal display element of Example 2 to Example 14 were separately prepared in the same steps as in Example 1, and the difference was that the type of the component and its use amount were changed, as shown in Table 3, Table 4 shows. The liquid crystal display elements obtained in Examples 2 to 14 were evaluated in the evaluation method described later, and the results are shown in Tables 3 and 4. Comparative Examples 1 to 3

比較例1至比較例3的液晶配向劑、液晶配向膜及液晶顯示元件是以與實施例1相同的步驟分別製備,不同的地方在於:改變成分的種類及其使用量,如表4所示。對比較例1至比較例3所製得液晶顯示元件以後述評價方式進行評價,其結果如表4所示。The liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element of Comparative Examples 1 to 3 were prepared in the same steps as in Example 1, except that the type of the component and the amount of use were changed, as shown in Table 4. . The liquid crystal display elements prepared in Comparative Examples 1 to 3 were evaluated in the evaluation method described later, and the results are shown in Table 4.

表3及表4中簡稱所對應的化合物如下所示。 The compounds corresponding to the abbreviations in Tables 3 and 4 are shown below.

[表3] [table 3]

[表4] 評價方式 積蓄電荷消除性 [Table 4] < Evaluation method > Elimination of accumulated charge

將利用實施例1至14及比較例1至3所製得之液晶顯示元件分別以3伏特的直流電壓施加30分鐘,接著以電氣測量機台(TOYO Corporation製,型號Model 6254)測量液晶顯示元件於電壓解除後之積蓄電壓(VR1 )及電壓解除後15分鐘之積蓄電壓(VR2 ),經下式(V)計算出積蓄電荷消除坡度(VS ),並依據以下基準進行評價:式(V) ◎:70%<VS 。 ○:65%<VS ≦70%。 △:60%<VS ≦65%。 ╳:VS ≦60%。 評價結果 The liquid crystal display elements prepared in Examples 1 to 14 and Comparative Examples 1 to 3 were each applied with a DC voltage of 3 volts for 30 minutes, and then the liquid crystal display elements were measured with an electric measuring machine (manufactured by TOYO Corporation, model number 6254). to release accumulated voltage of the voltage (V R1) and the voltage is released after 15 minutes accumulated voltage (V R2), is calculated by the following formula (V) the accumulated charge elimination slope (V S), and evaluated based on the following criteria: Formula (V) ◎: 70% <V S. ○: 65% <V S ≦ 70%. △: 60% <V S ≦ 65%. ╳: V S ≦ 60%. Evaluation results

由表3以及表4得知,當液晶配向劑中的聚合物(A)的四羧酸二酐組份(a)不包括由式(a-1)表示的化合物(a1)(比較例1至3)時,液晶顯示元件的積蓄電荷消除性不佳。As can be seen from Tables 3 and 4, when the tetracarboxylic dianhydride component (a) of the polymer (A) in the liquid crystal alignment agent does not include the compound (a1) represented by the formula (a-1) (Comparative Example 1) To 3), the stored charge erasability of the liquid crystal display element is not good.

此外,當液晶配向劑中的聚合物(A)的二胺組份(b)包括由式(b-1)表示的二胺化合物(b1)(實施例3至6、10至13)時,也可進一步提升液晶顯示元件的積蓄電荷消除性。In addition, when the diamine component (b) of the polymer (A) in the liquid crystal alignment agent includes the diamine compound (b1) represented by the formula (b-1) (Examples 3 to 6, 10 to 13), It is also possible to further improve the stored charge erasability of the liquid crystal display element.

另外,當液晶配向劑中的聚合物(A)的二胺組份(b)包括由式(b-2)表示的二胺化合物(b2)(實施例1至4、8至11)時,可進一步提升液晶顯示元件的積蓄電荷消除性。In addition, when the diamine component (b) of the polymer (A) in the liquid crystal alignment agent includes the diamine compound (b2) represented by the formula (b-2) (Examples 1 to 4, 8 to 11), It is possible to further improve the stored charge erasability of the liquid crystal display element.

綜上所述,本發明的液晶配向劑中,因為形成聚合物(A)的混合物中的四羧酸二酐組份(a)包括由式(a-1)表示的化合物(a1),因此使用該液晶配向劑所製得的液晶配向膜能夠改善積蓄電荷消除緩慢的問題。In summary, in the liquid crystal alignment agent of the present invention, since the tetracarboxylic dianhydride component (a) in the mixture forming the polymer (A) includes the compound (a1) represented by the formula (a-1), The liquid crystal alignment film prepared by using the liquid crystal alignment agent can improve the problem of slow accumulation of charge and elimination.

另一方面,本發明的液晶配向劑中,因為形成聚合物(A)的混合物中的二胺組份(b)包括選自由式(b-1)表示的二胺化合物(b1)以及由式(b-2)表示的二胺化合物(b2)中的任一者以上,而使液晶顯示元件的積蓄電荷消除性進一步提升,因此適用於製造液晶配向膜及液晶顯示元件。On the other hand, in the liquid crystal alignment agent of the present invention, the diamine component (b) in the mixture forming the polymer (A) includes a diamine compound (b1) selected from the formula (b-1) and Any one or more of the diamine compounds (b2) represented by (b-2) can further improve the stored charge erasability of the liquid crystal display element, and is therefore suitable for producing a liquid crystal alignment film and a liquid crystal display element.

雖然本發明已以實施例揭露如上,然其並非用以限定本發明,任何所屬技術領域中具有通常知識者,在不脫離本發明的精神和範圍內,當可作些許的更動與潤飾,故本發明的保護範圍當視後附的申請專利範圍所界定者為準。Although the present invention has been disclosed as above with the examples, it is not intended to limit the present invention. Any person with ordinary knowledge in the technical field can make some modifications and retouching without departing from the spirit and scope of the present invention. The protection scope of the present invention shall be determined by the scope of the attached patent application.

100‧‧‧液晶顯示元件100‧‧‧LCD display element

110‧‧‧第一單元110‧‧‧ Unit 1

112‧‧‧第一基板112‧‧‧First substrate

114‧‧‧電極114‧‧‧ electrode

116‧‧‧第一液晶配向膜116‧‧‧The first liquid crystal alignment film

120‧‧‧第二單元120‧‧‧ Unit 2

122‧‧‧第二基板122‧‧‧Second substrate

126‧‧‧第二液晶配向膜126‧‧‧Second LCD alignment film

130‧‧‧液晶單元130‧‧‧LCD unit

圖1是根據本發明一實施例的液晶顯示元件的側視圖。FIG. 1 is a side view of a liquid crystal display element according to an embodiment of the present invention.

Claims (10)

一種液晶配向劑,包括: 聚合物(A);以及 溶劑(B), 其中,所述聚合物(A)是由混合物反應而獲得,所述混合物包括四羧酸二酐組份(a)及二胺組份(b), 所述四羧酸二酐組份(a)包括由式(a-1)表示的化合物(a1):式(a-1) 式(a-1)中, L1 各自獨立表示氫原子、碳數為1至10的烷基、碳數為1至10的烷氧基、氟原子、氯原子或溴原子; L2 各自獨立表示碳數為1至3的烷基; a各自獨立表示0至3的整數; b表示0至4的整數。A liquid crystal alignment agent includes: a polymer (A); and a solvent (B), wherein the polymer (A) is obtained by reacting a mixture including a tetracarboxylic dianhydride component (a) and A diamine component (b), and the tetracarboxylic dianhydride component (a) includes a compound (a1) represented by the formula (a-1): Formula (a-1) In formula (a-1), L 1 each independently represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, a fluorine atom, a chlorine atom, or bromine An atom; L 2 each independently represents an alkyl group having 1 to 3 carbon atoms; a each independently represents an integer of 0 to 3; b represents an integer of 0 to 4; 如申請專利範圍第1項所述的液晶配向劑,其中所述二胺組份(b)包括由式(b-1)表示的二胺化合物(b1):式(b-1) 式(b-1)中, R1 各自獨立表示氫原子、碳數為1至10的烷基、碳數為1至10的烷氧基、乙醯胺基、氟原子、氯原子或溴原子; R2 各自獨立表示碳數為1至3的烷基; m各自獨立表示0至3的整數; n表示0至4的整數。The liquid crystal alignment agent according to item 1 of the scope of patent application, wherein the diamine component (b) includes a diamine compound (b1) represented by the formula (b-1): Formula (b-1) In formula (b-1), R 1 each independently represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, an acetamido group, or a fluorine atom. , A chlorine atom or a bromine atom; R 2 each independently represents an alkyl group having 1 to 3 carbon atoms; m each independently represents an integer of 0 to 3; n represents an integer of 0 to 4; 如申請專利範圍第2項所述的液晶配向劑,其中在所述式(b-1)中,R1 各自獨立表示氫原子、碳數為1至10的烷基、碳數為1至10的烷氧基或乙醯胺基。The liquid crystal alignment agent according to item 2 of the scope of patent application, wherein in the formula (b-1), each of R 1 independently represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, and a carbon number of 1 to 10 Alkoxy or acetamido. 如申請專利範圍第1項所述的液晶配向劑,其中所述二胺組份(b)包括由式(b-2)表示的二胺化合物(b2):式(b-2) 式(b-2)中,h表示1至12的整數。The liquid crystal alignment agent according to item 1 of the scope of patent application, wherein the diamine component (b) includes a diamine compound (b2) represented by the formula (b-2): Formula (b-2) In Formula (b-2), h represents an integer of 1-12. 如申請專利範圍第1項所述的液晶配向劑,其中基於所述四羧酸二酐組份(a)的總莫耳數為100莫耳,所述由式(a-1)表示的化合物(a1)的使用量為2至20莫耳。The liquid crystal alignment agent according to item 1 of the scope of patent application, wherein the total mole number based on the tetracarboxylic dianhydride component (a) is 100 moles, and the compound represented by the formula (a-1) (A1) is used in an amount of 2 to 20 mol. 如申請專利範圍第2項所述的液晶配向劑,其中基於所述二胺組份(b)的總莫耳數為100莫耳,所述由式(b-1)表示的二胺化合物(b1)的使用量為2至20莫耳。The liquid crystal alignment agent according to item 2 of the scope of patent application, wherein the total mole number based on the diamine component (b) is 100 moles, and the diamine compound represented by formula (b-1) ( b1) is used in an amount of 2 to 20 moles. 如申請專利範圍第4項所述的液晶配向劑,其中基於所述二胺組份(b)的總莫耳數為100莫耳,所述由式(b-2)表示的二胺化合物(b2)的使用量為10至80莫耳。The liquid crystal alignment agent according to item 4 of the scope of patent application, wherein the total mole number based on the diamine component (b) is 100 moles, and the diamine compound represented by formula (b-2) ( b2) The amount used is 10 to 80 mol. 如申請專利範圍第1項所述的液晶配向劑,其中基於所述聚合物(A)的總使用量為100重量份,所述溶劑(B)的使用量為800至4000重量份。The liquid crystal alignment agent according to item 1 of the scope of patent application, wherein based on the total used amount of the polymer (A) is 100 parts by weight, and the used amount of the solvent (B) is 800 to 4000 parts by weight. 一種液晶配向膜,其是由如專利申請範圍第1項至第8項中任一項所述的液晶配向劑而形成。A liquid crystal alignment film is formed from the liquid crystal alignment agent according to any one of the first to eighth patent application scopes. 一種液晶顯示元件,其包括如專利申請範圍第9項所述的液晶配向膜。A liquid crystal display element includes the liquid crystal alignment film according to item 9 of the scope of patent application.
TW105131504A 2016-09-30 2016-09-30 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device TWI659981B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW105131504A TWI659981B (en) 2016-09-30 2016-09-30 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device
CN201710872247.6A CN107880902B (en) 2016-09-30 2017-09-25 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display assembly

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW105131504A TWI659981B (en) 2016-09-30 2016-09-30 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device

Publications (2)

Publication Number Publication Date
TW201811864A true TW201811864A (en) 2018-04-01
TWI659981B TWI659981B (en) 2019-05-21

Family

ID=61780734

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105131504A TWI659981B (en) 2016-09-30 2016-09-30 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device

Country Status (2)

Country Link
CN (1) CN107880902B (en)
TW (1) TWI659981B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI740043B (en) * 2018-05-18 2021-09-21 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7375759B2 (en) * 2018-08-20 2023-11-08 日産化学株式会社 Liquid crystal alignment agent, manufacturing method thereof, liquid crystal alignment film, and liquid crystal display element
CN112266478B (en) * 2020-10-30 2023-05-12 深圳市道尔顿电子材料有限公司 Polyimide with low body resistance, preparation method and application thereof, polyimide film and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013015773A (en) * 2011-07-06 2013-01-24 Jsr Corp Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display element
US9909065B2 (en) * 2012-04-24 2018-03-06 Jnc Corporation Liquid crystal aligning agents for forming photo-aligning liquid crystal alignment layers, liquid crystal alignment layers and liquid crystal display devices using the same
JP6056187B2 (en) * 2012-05-09 2017-01-11 Jnc株式会社 Liquid crystal alignment agent, liquid crystal alignment film for forming liquid crystal alignment film for photo-alignment, and liquid crystal display element using the same
TWI503610B (en) * 2013-05-03 2015-10-11 Chi Mei Corp Liquid crystal alignment composition, liquid crystal alignment film and liquid crystal display device having thereof
TWI521017B (en) * 2014-02-14 2016-02-11 奇美實業股份有限公司 Liquid crystal alignment composition, liquid crystal alignment film and liquid crystal display device having thereof
TWI527857B (en) * 2014-05-15 2016-04-01 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device
TWI565756B (en) * 2015-03-04 2017-01-11 奇美實業股份有限公司 Composition for liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element having the same
TWI564346B (en) * 2015-03-27 2017-01-01 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI740043B (en) * 2018-05-18 2021-09-21 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Also Published As

Publication number Publication date
CN107880902B (en) 2023-07-25
CN107880902A (en) 2018-04-06
TWI659981B (en) 2019-05-21

Similar Documents

Publication Publication Date Title
TWI468441B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device having thereof
TWI492968B (en) Liquid crystal alignment agent, liquid crystal display element and polyorganosiloxane
TWI427375B (en) Vertical alignment mode liquid crystal alignment agent and liquid crystal display device
TWI448790B (en) Liquid crystal alignment film and liguid crystal display element
JP5013106B2 (en) Liquid crystal aligning agent and liquid crystal display element
TWI640573B (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP5071662B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP5633667B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP5585755B2 (en) Liquid crystal aligning agent and liquid crystal display element
TWI659981B (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device
JP5099350B2 (en) Liquid crystal aligning agent and liquid crystal display element
TWI467290B (en) Liquid crystal aligning agent, liquid crystal display element, polyamic acid, polyimide and compound
JP4868167B2 (en) Liquid crystal aligning agent and liquid crystal display element
TW201905039A (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP5488798B2 (en) Liquid crystal alignment agent
JP5590304B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP5376165B2 (en) Liquid crystal aligning agent and liquid crystal display element
TWI457421B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI666232B (en) Liquid crystal alignment agent and production method thereof, liquid crystal alignment film and production method thereof, and liquid crystal display element
TWI649351B (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP5158351B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP5316752B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP2006227597A (en) Liquid crystal aligning agent and liquid crystal display element
TW201915089A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW201912768A (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element